Nómina de la Bibliografía del Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben" desde 1957 hasta la fecha:

• Ingresá a la bibliografía en el Repositorio Digital del ANLIS
• Para buscar por palabra clave: Ctrl + F

1957 – 1969

• Rosenbaum MB, Cerisola JA. Encuesta sobre Enfermedad de Chagas en el norte de Córdoba y sur de Santiago del Estero. Prensa Méd Argent. 1957; 44: 2713-27
• Rosenbaum MB, Alvarez M, Cerisola JA. El peligro de la transmisión de la Enfermedad de Chagas por la transfusión sanguínea. Prensa Méd Argent. 1957; 44: 3305-8.
• Rosenbaum MB, Cerisola JA. Encuesta sobre Enfermedad de Chagas en la Provincia de La Pampa. Prensa Méd Argent. 1957; 44: 3485-93.
• Rosenbaum MB, Cerisola JA. Encuesta sobre Enfermedad de Chagas en la Provincia de La Rioja. Prensa Méd Argent. 1958; 45: 1013-26.
• Cerisola JA, Rosenbaum MB. La reacción de fijación de complemento para el diagnóstico de la enfermedad de Chagas. I. Técnica. Prensa Méd Argent. 1958; 45: 1454-63.
• Rosenbaum MB, Cerisola JA. La reacción de fijación de complemento para el diagnóstico de la enfermedad de Chagas. II. Valoración clínica. Prensa Méd Argent. 1958; 45: 1551-60.
• Rosenbaum MB, Cerisola JA. Epidemiología de la Enfermedad de Chagas en Argentina. O Hospital. 1961; 60 (1):25-124.
• Cerisola JA, Fatala Chabén M, Lázzari JO. Test de hemaglutinación para el diagnóstico de la enfermedad de Chagas. Pren Méd Argent. 1962; 49: 1761-7
• Cerisola JA, Fatala Chabén M, Lazzari JO. Test de hemaglutinación para el diagnóstico de la Enfermedad de Chagas. Buenos Aires, Dirección de Enfermedades Transmisibles. Laboratorio Sanitario; 1963.
• Vilaseca GC, Cerisola JA, Olarte JA, Zothner A. The use of crystal violet in the prevention of the transfusional transmission of Chagas-Mazza disease. Vox Sang. 1966; 11: 711-6.
• Kuschnir, E., Cichero, J.A., Yabo, R., Segura, E.L. Estudios comparativos de los resultados de la reacción de fijación del complemento para diagnostico de la Enfermedad de Chagas-Mazza. Correlación entre cuatro laboratorios. Rev. Fac. C. Med. Córdoba, Arg. 1967; 54: 155-159.
• Cerisola JA. Serología de la enfermedad de Chagas. Seg. Jorn. Entomepid. Arg. 1967; 1:167-72
• Cerisola JA, Rohwedder RW, Di Corleto CA. Estimación de la especificidad de reacciones serológicas para enfermedad de Chagas. I. Sueros de zona libre de trypanosomiasis. Bol Chil Parasitol. 1968; 23: 2-3.
• Alvarez M, JA Cerisola, RW Rohwedder. Test de inmunofluorescencia para el diagnóstico de la enfermedad de Chagas. Bol Chil Parasitol. 1968; 23: 4-9.
• Cabral, H.R.A., Segura Seco, E.L., Paolasso, E.R.W. de, Castoldi, F., Veloso, M. and Cichero, J.A. Enfermedad de Chagas aguda y autoinmunidad (Hipótesis sobre patogenia de la injuria tisular e intento de verificación experimental). Rev. Fac. de C. Med. Córdoba, Arg. 1968;25: 419-431.
• Bonet, A.H., Cichero, J.A., Kuschnir, E., Grand, J.C. and Segura, E.L. Estudio epidemiológico sobre la Enfermedad de Chagas-Mazza en comunidades rurales de la Provincia de Córdoba. (Encuesta serológica y electrocardiográfica). Sem. Med. 1968; 133 (18): 581-614.
• Cichero, J.A., Santamarina, N.O., Segura, E.L., Grand, J.C. Estudio de la prevalencia de la Enfermedad de Chagas en varones de 20 años de edad en la provincia de Santiago del Estero. Sem. Med. 1968; 133: 1972-1978.
• Cerisola JA, Alvarez M, Lugones H, Rebosolán JB. Sensibilidad de las reacciones serológicas para el diagnóstico de la enfermedad de Chagas. Bol Chil Parasitol. 1969; 24: 2-8.
• Cerisola JA. Evolución serológica de pacientes con enfermedad de Chagas aguda tratados con Bay 2502. Bol Chil Parasitol. 1969; 24: 54-9.
• Cichero, J.A., Segura, E.L. and Quatrochi, J.C. Evolución clínico-parasitólogica y tolerancia a la droga de 33 niños con infección chagásica crónica tratados con Bay 2502. Bol. Chil. Parasitol. 1969; 24 (1-2): 59-62.

1970 – 1979

• Rohwedder RW, Del Prado CE, Cerisola JA, Rebosolán JB. Aportes al método del xenodiagnóstico previo licuado de los triatominos. Bol Chil Parasitol. 1970; 25: 106-10.
• Cerisola JA, Alvarez M, De Rissio AM. Inmunodiagnóstico da doença de Chagas. Evoluçao serológica de pacientes com doença de Chagas. Rev Inst Med Trop S Paulo. 1970; 12: 403-11.
• Lelchuk R, Dalmasso AP, Inglesini CL, Alvarez M, Cerisola JA. Immunoglobulin studies in serum of patients with American Trypanosomiasis (Chagas’ disease). Clin exp Immunol. 1970; 6: 547-55.
• Cerisola JA, Alvarez M, Block M, Wegner D. A comparison of a new antigen from amastigotes of Trypanosoma cruzi and an antigen from epimastigotes for the diagnosis of Chagas’ disease by the indirect immunofluorescence test. Rev Inst Med Trop S Paulo. 1971; 13: 162-6.
• Cerisola JA, del Prado CE, Rohwedder R, Bozzini JP. Blastocrithidia triatomae (n. sp.) found in Triatoma infestans from Argentina. J Protozool 1971; 18: 503-6.
• Alvarez, M.; Martini, J.W.de; De Rissio, A.M.; del Prado, C.E.y Cerisola, J.A. . Técnica de Inmunofluorescencia directa para la identificación inmunológica de Trypanosoma cruzi y Blastocrithidia triatomae. Bioquímica Clínica (Argentina). 1971; 5 (1): 52-59.
• Alvarez M, De Rissio AM, de Martini GJW, Abramo Orrego L, Cerisola JA. Recolección de sangre en papel para diagnóstico de infección chagásica por inmunofluorescencia. Bol Chil Parasit. 1971; 26: 2-6.
• Cerisola JA, Rohwedder R, del Prado CE. Rendimiento del xenodiagnóstico en la infección chagásica crónica humana utilizando ninfas de diferentes especies de triatominos. Bol Chil Parasit. 1971; 26: 57-8.
• Cerisola JA, Rabinovich A, Alvarez M, Di Corleto CA, Pruneda J. Enfermedad de Chagas y transfusión de sangre. Bol Of Sanit Panam. 1972; 62: 203-21.
• Alvarez, M.; Martini, J.W.de; De Rissio, A.M.; Abramo Orrego, L.del R. . Reacción de Inmunofluorescencia con coloración del complemento. Su aplicación en zoonosis, para la enfermedad de Chagas. Bioquímica Clínica. 1972; Vol. VI (1): 55-62.
• Perassi R. Protein components of the haemolymph of triatomid bugs (hemiptera: reduvidiidae). Bol Chil Parasit. 1972; 27: 74-80.
• Perassi R. Antigenic components in Triatomoma infestans haemolymph. J Insect Physiol. 1972; 18: 1961-6.
• Cerisola JA, Rosenbaum M, Lugones H, Rabinovich LB. Diagnóstico de la Enfermedad de Chagas: I. Rese–as Diag. 1973; 6(1):1-10.
• Cerisola JA, Alvarez M, Wynne de Martini GJ. Diagnóstico de la Enfermedad de Chagas: II. Rese–as Diag. 1973; 6(2):1-10.
• Perassi R. Female specific proteins in Triatoma infestans haemolymph. J. Insect Physiol. 1973; 19: 663-71.
• Segura EL, Cura EN, Paulone I, Vazquez C, Cerisola JA. Antigenic make up of subcellular fractions of Trypanosoma cruzi . J Protozool. 1974; 21: 571-4.
• Cerisola JA, Rohwedder R, Segura EL, Del Prado CE, de Martini GJW. El Xenodiagnóstico. Normalización. Utilidad. Premio Lab. Ciba-Geigy, Sec Est Salud Pública Ed. Buenos Aires. 1974: 1-127.
• Perassi R, Cerisola JA. Antigenic components in haemolymph of some reduviis (Hemiptera, Reduviidae). Canadian Journal of Zoology. 1974; V52 No 1:43-45.
• Segura EL, Campos JM, Bronzina A, Cerisola JA. Antígenos de las fracciones subcelulares del Trypanosoma cruzi. I Localización de antígenos y proteínas en las fracciones subcelulares. Medicina (Buenos Aires)1975; 35: 451-9.
• Perassi R, Segura EL. Degradation of serum proteins in Triatoma infestans. Exp Parasitol. 1976; 40: 1-4.
• Gonzalez Cappa SM, Cantarella AI, Lajmanovich S, Segura EL. Experimental Chagas’ disease: studies on the stability of a protective antigen. J Parasitol. 1976; 62: 130-1.
• Segura EL, Paulone I, Cerisola JA, Gonzalez Cappa SM. Experimental Chagas’ disease: protective activity in relation with subcellular fractions of the parasite. J Parasitol. 1976; 62: 131-3.
• Gerez de Burgos NM, Burgos C, Blanco A, Paulone I, Segura EL. Actividad hidroxiácido-dehidrogenasa en Trypanosoma cruzi . Acta Physiol Latinoam. 1976; 26: 10-9.
• Bronia DIH de, Montamat EE, Aeberhard EE, Segura EL. Composición lipídica del Trypanosoma cruzi. Medicina (Buenos Aires) 1976; 36: 294-8.
• Juan SM, Cazzulo JJ, Segura EL. Algunas propiedades de la malato dehidrogenasa de Trypanosoma cruzi Rev Asoc Arg Microbiol. 1976; 8: 114-6.
• Juan SM, Cazzulo JJ, Segura EL. The pyruvate kinase of Trypanosoma cruzi. Acta Physiol Latinoam. 1976; 26: 424-6.
• Cazzulo JJ, Juan SM, Segura EL. Glutamate dehydrogenase and aspartate amino-transferase in Trypanosoma cruzi . Comp Biochem Physiol. 1976; 56B: 301-3.
• Juan SM, Cazzulo JJ, Segura EL. The citrate synthase from Trypanosoma cruzi. J Parasitol. 1977; 63: 921-2.
• Cataldi de Flonbaum MA, Cannata JJB, Cazzulo JJ, Segura EL. CO2 fixing enzymes in Trypanosoma cruzi. Comp Biochem Physiol. 1977; 58B: 67-9.
• Cazzulo JJ, Juan SM, Segura EL. The malic enzyme from Trypanosoma cruzi. J Gen Microbiol. 1977; 99: 237-41.
• Segura EL, Vazquez C, Bronzina A, Campos JM, Cerisola JA, Gonzalez Cappa SM. Antigens of subcellular fractions of Trypanosoma cruzi. II Flagelar and membrane fractions. J Protozool. 1977; 24: 540-3.
• Cerisola JA. Epidemiología de la enfermedad de Chagas en zonas de alta endemicidad en Argentina. Rev Neurol Arg. 1977; 3: 411-419.
• D’Alessandro A, del Prado CE. Search for Trypanosoma cruzi in Argentina and Brasil. Am J Trop Med Hyg. 1977; 26: 623-7.
• Bronzina A, Ribeiro dos Santos R, Marquez JO, Cerisola JA, Segura EL. Afinidad de los antígenos de Trypanosoma cruzi por los tejidos de rata. Rev Neurol Arg 1977; 3: 483.
• Cerisola JA, Silva NN, Prata A, Schenone H, Rohwedder R. Evaluación mediante xenodiagnóstico de la efectividad del nifurtimox en la infección chagásica crónica humana. Bol.Chil.Parasitol. 1977; 32(3-4): 51-62.
• Cerisola JA, Chemoterapy of Chagas´ infection in man, Reprinted from Chagas disease, PHAO Scientific publication N 347. 1977; 35-47.
• Frasch AC, Segura EL, Cazzulo JJ, Stoppani AO. Adenosine triphosphatase activities in Trypanosoma cruzi . Comp Biochem Physiol. 1978; 60B: 271-5.
• Patrucco A, Cerisola JA, Michel M, Chiale P, Alvarez M, Segura EL. Flagellar antigens and leucocyte migration-inhibition test in Chagas’ patients. Trans Roy Soc Trop Med Hyg. 1978; 72: 425-6.
• Gerez de Burgos NM, Blanco A, Segura EL. Formas moleculares de alfa-hidroxiácidos dehidrogenasa en Trypanosoma cruzi. Medicina (Buenos Aires) 1978; 38: 151-4.
• Juan SM, Segura EL, Cazzulo JJ. Purification and some properties of the NADP- linked glutamate dehydrogenase from Trypanosoma cruzi . Int J Biochem. 1978; 9: 395-400.
• Bronia DIH de, Montamat EE, Aeberhard EE, Segura EL. Fosfolípidos y otros componentes lipídicos de Trypanosoma cruzi . Estudio comparativo de cepas Tulahuén, ES y Brasil. Medicina (Buenos Aires) 1978; 38: 255-8.
• Juan SM, Segura EL, Cazzulo JJ. Inhibition of the NADP-linked glutamate dehydrogenase from Trypanosoma cruzi by sulfhydryl reagents. Comp Biochem Physiol. 1979; 63(B): 531-5.
• Cazzulo JJ, Franke de Cazzulo B, Higa AI, Segura EL. NADP-linked glutamate dehydrogenase in Trypanosoma cruzi. Comp Biochem Physiol 1979; 64(B): 129-31.
• Cannata JJB, Frasch ACC, Cataldi de Flonbaum MA, Segura EL, Cazzulo JJ. Two forms of «malic» enzyme with different regulatory properties in Trypanosoma cruzi . Biochem J. 1979; 184: 409-19.
• Olabuenaga SE, Cardoni RL, Segura EL, Riera NE, de Bracco MME. Antibody-dependent cytolysis of Trypanosoma cruzi by human polymorphonuclear leukocytes. Cell Immunol. 1979; 45: 85-93.
• Juan SM, Segura EL, Cazzulo JJ. Inhibition of the NADP-linked glutamate dehydrogenase from Trypanosoma cruzi by silver nitrate. Experientia. 1979; 35:1139-40.

1980 – 1989

• Barousse AP, Costa JA, Eposto M, Laplume H, Segura EL. Enfermedad de Chagas e inmunosupresión. Medicina (Buenos Aires) 1980; 40 Supl 1: 17-26.
• Bronzina A, D’Alessandro A, Segura EL. Diferencias y similitudes antigénicas entre Trypanosoma rangeli y Trypanosoma cruzi . Medicina (Buenos Aires) 1980; 40 Supl 1: 45-9.
• Abramo Orrego L, Lansetti JC, Bozzini JP, de Martini GJW. Hemocultivo como método de diagnóstico de la enfermedad de Chagas. Medicina (Buenos Aires) 1980; 40 Supl 1: 56-62.
• Gonzalez Cappa SM, Chiale P, Del Prado CE, Katzin AM, de Martini GJW, Abramo Orrego L, Segura EL. Aislamiento de una cepa de Trypanosoma cruzi de un paciente con miocardiopatía chagásica crónica y su caracterización biológica. Medicina (Buenos Aires) 1980; 40 Supl 1: 63-8.
• Segura EL, Subias E, Esteva MI, Cabeza Meckert P, Bronzina A, Laguens R. Características de infectividad de tres subpoblaciones de cultivo de Trypanosoma cruzi. Medicina (Buenos Aires) 1980; 40 Supl 1: 97-102.
• Engel JC, Perez AC, GJW de Martini. Criopreservación de Trypanosoma cruzi. Medicina (Buenos Aires) 1980; 40 Supl 1: 103-8.
• Martini GJW de, Abramo Orrego L, de Rissio AM, Alvarez M, Mujica LP. Cultivo de Trypanosoma cruzi en un medio monofásico. Su aplicación en cultivos en gran escala en procesos de fermentación. Medicina (Buenos Aires) 1980; 40 Supl 1: 109-14.
• Cerisola JA, Alvarez M, Martini GJW de. Reacción de aglutinación de partículas de látex para el diagnóstico de la enfermedad de Chagas. Medicina (Buenos Aires) 1980; 40 Supl 1: 132-6.
• Bronia DIH, Aeberhard EE, Montamat EE, Segura EL. Acidos grasos de Trypanosoma cruzi . Medicina (Buenos Aires) 1980; 40 Supl 1: 154-8.
• Lederkremer RM de, Casal OL, de Rissio AM, GJW de Martini. El lipopéptido- fosfoglicano del Trypanosoma cruzi. Variación de las bases esfingosínicas. Medicina (Buenos Aires) 1980; 40 Supl 1: 245-7.
• Mujica P, Fontana LE, Moreno M, Russo MC, Alvarez M. Encuesta serológica y electrocardiográfica en la población del Departamento de Monte Caseros, Corrientes. Medicina (Buenos Aires) 1980; 40 Supl I: 251-2.
• Segura EL, Engel JC, Katzin VJ, Subias E, de Isola ED, Esteva MI, Lammel E, De Rissio AM, Gonzalez Cappa SM. Variación en la capacidad infectante de formas del Trypanosoma cruzi. Medicina (Buenos Aires) 1980; 40 Supl 1: 256-7
• Lansetti JC, Giordano AD, Subias E, Segura EL. Reacciones serológicas de descarte de la infección chagásica. Medicina (Buenos Aires) 1980; 40 Supl 1: 258-9.
• Gonzalez Cappa SM, Bronzina A, Katzin AM, Golfera H, GW de Martini, Segura EL. Antigens of subcellular fractions of Trypanosoma cruzi . III. Humoralimmune response and histopathology of immunized mice. J Protozool. 1980; 27: 467-71.
• Segura EL. Antígenos del Trypanosoma cruzi. Acta Bioq Clin Latinoam. 1980; 14: 317-8.
• Cazzulo JJ, Franke de Cazzulo B, Segura EL. Inhibition of the NAD-linked glutamate dehydrogenase from Trypanosoma cruzi by sulphydryl reagents. Comp Biochem Physiol. 1980; 67(B): 163-6.
• Neal RA, de Deffis M, Segura EL. Susceptibility of Triatoma infestans from two laboratory colonies to infection with Trypanosoma cruzi . Trans Roy Soc Trop Med Hyg. 1980; 74: 550-1.
• Lustig ES de, Puricelli L, Lansetti JC. Association of Chagas’ disease and cancer. Medicina (Buenos Aires) 1980; 40: 43-6.
• Bolomo N, Milei J, Cossio PM, Segura EL, Laguens RP, Fernandez LM, Arana RM. Enfermedad de Chagas experimental en un primate sudamericano (Cebus sp). Medicina (Buenos Aires) 1980; 40: 667-72.
• Segura EL, Esteva MI, Quintans CJ, Montoro LS, Weissenbacher MC. Infección con Trypanosoma cruzi en ratones congénitamente atímicos. Medicina (Buenos Aires) 1981; 41: 328-32.
• Bolomo N, Milei J, Cossio PM, Nagle C, Arana RM, Del Prado CE, Segura EL. Infección crónica por Trypanosoma cruzi en el Cebus sp. adulto. Medicina (Buenos Aires) 1981; 41: 678-9.
• Torruela M, Franke de Cazzulo B, Engel JC, Ruiz AM, Segura EL, Cazzulo JJ. Trypanosoma cruzi and Trypanosoma rangeli : glutamate dehydrogenase and proteolytic activities. Comp Biochem Physiol. 1981; 70(B): 463-8.
• Segura EL. Inmunología de la Enfermedad de Chagas. en Enfermedad de Chagas (R Posse, G Mouzo, N Barros Ed.) Buenos Aires. 1981: 71-5.
• Parodi AJ, Quesada Allue LA, Cazzulo JJ. The pathway of protein glycosylation in the Trypanosomatid Crithidia fasciculata . Proc Natl Acad Sci U S A- Biol Sci. 1981; 78 (10): 6201-5.
• Frasch ACC, Goijman SG, Cazzulo JJ, Stoppani AOM. Constant and variable regions in DNA minicircles from Trypanosoma cruzi and Trypanosoma rangeli : application to species and stock differentiation. Mol Biochem Parasitol. 1981; (3-4): 163-70.
• Wynne de Martini GJ. El diagnóstico parasitológico y serológico de la Enfermedad de Chagas. EN: Posse RA, Mouzo de Martone G, Barrio N. Reunión internacional sobre Enfermedad de Chagas: homenaje a Carlos Chagas, centenario de su natalicio. Buenos Aires: CH Boehringer Sohn. 1981: 89-97.
• Travi B, Ruiz AM, Colillas OJ, Segura EL. Trypanosomiasis en monos americanos. I. Prevalencia de la infección en colonias de cría y vida salvaje. Medicina (Buenos Aires) 1982; 42: 55-60.
• Campanini AR de, Esteva MI, Laguens RP, Segura EL. Trypanosoma cruzi and immunoprotection: study of an attenuated strain. Medicina (Buenos Aires) 1982; 42: 502-6.
• Engel JC, Dvorak JA, Segura EL, Crane MStJ. Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium. J Protozool. 1982; 29: 555-60.
• De Titto EH, Braun M, Segura EL. Density gradient purification of human lymphocytes from contaminating trypomastigotes of Trypanosoma cruzi. J Immunol Methods. 1982; 50: 281-7.
• Lederkremer RM de, Waksman N, GJW de Martini, Segura EL. The glycoconjugates from Trypanosoma cruzi. Purification and composition of a glycoprotein. Comp Biochem Physiol. 1982; 72: 313-6.
• Montamat E, Gerez de Burgos N, Burgos C, Rovai L, Segura EL, Blanco A. Inhibitory actions of gossypol on enzymes and growth of Trypanosoma cruzi . Science. 1982; 218: 288-9.
• Hajos SE, Carbonetto C, Margni RA, Esteva MI, Segura EL. Purification and properties of anti-Trypanosoma cruzi antibodies isolated from patients with Chagas’ disease. Immunol Letters. 1982; 4: 199-203.
• Travi B, Schudel A, Colillas OJ, Segura EL. Zoonosis en primates: toxoplasmosis, Herpes simplex tipo I, Epstein-barr y parainfluenza 3. Rev Med Vet (Bs As) 1982; 63: 237-41.
• Gonzalez Cappa SM, Segura EL. Enfermedad de Chagas. Jano. 1982; 14: 53-63.
• Gonzalez Cappa SM, EL Segura. Enfermedad de Chagas. Adel Microbiol Enf Infec. 1982; 1: 51-102.
• Franke de Cazzulo B, JJ Cazzulo. Inhibition by suramin of the glutamate dehydrogenases from Trypanosoma cruzi and bovine liver. Comp Biochem Physiol. 1982; 71B:321.
• Rosenstein, A., Esteva, M., Laguens, R.P. and Segura, E.L. Trypanosoma cruzi and immunoprotection study of an attenuated strain. Medicina (Buenos Aires). 1982; 42: 502-506.
• Roveri OA, Franke de Cazzulo B, Cazzulo JJ. Inhibition by suramin of oxidative phosphorylation in Crithidia fasciculata. Comp Biochem Physiol. 1982; 71(B): 611-6.
• Salvarrey MS, Cazzulo JJ. Citrate synthase from Crithidia fasciculata: inhibition by adenine nucleotides and suramin. Comp Biochem Physiol. 1982; 72(B): 165-8.
• Parodi AJ, Cazzulo JJ. Protein glycosylation in Trypanosoma cruzi. II. Partial characterization of protein-bound oligosaccharides labeled «in vivo». J Biol Chem. 1982; 257: 7641-5.
• Cannata JJB, Valle E, Docampo R, Cazzulo JJ. Sucellular localization of phospho-enolpyruvate carboxykinase in the trypanosomatids Trypanosoma cruzi and Crithidia fasciculata. Mol Biochem Parasitol. 1982; 6: 151-60.
• Cazzulo JJ, BM Franke de Cazzulo. Proteolytic activity on endogenous substrates in cell-free extracts of Trypanosoma cruzi. Experientia. 1982; 38:1335.
• Dvorak JA, Hall TE, Crane MStJ, Engel JC, McDaniel JP, Uriegas P. Trypanosoma cruzi : Flow cytometric analysis of total DNA/organism by means of mithromycin-induced fluorescence. J Protozool. 1982; 29: 430-7.
• Wisnivesky-Colli C, Gürtler R, Solarz N, Salomon D, Ruiz AM. Feeding pattern of Triatoma infestans (Hemiptera: Reduvidiidae) in relation to transmission of American Trypanosomiasis in Argentina. J Med Entomol. 1982; 19 (6): 645-654.2
• Cazzulo JJ. Aminoacid metabolism in Trypanosoma cruzi. en Application of Biochemical Micromethods for the Investigation of Tropical Disease Pathogens (F Michal Ed.). UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases, Geneva, Switzerland; 1982: 179-182.
• Subias, E., Montoro, L., Laguens, R., Elizari, M., Segura, E. Influence of dose of parasites on the infection with Trypanosoma cruzi of congenitally athymic mice. J. Protozool. 1982; 29(2): 323-324.
• De Titto EH, Segura EL, Braun M. Cellular immunity in Chagas’ disease patients. Lymphoproliferative response to subcellular fractions of Trypanosoma cruzi. Immunol Letters. 1983; 6: 161-7.
• De Titto EH, Braun M, Lázzari JO, Segura EL. Evaluación de la respuesta detectada por linfoproliferación en pacientes chagásicos crónicos. Chagas. 1983; 1:45-52.
• Torruella M, Molina y Vedia L, Flawia MM, Torres HN, Cazzulo JJ, Subias E, Segura EL. Monoclonal antibodies against proteins associated to membranes of Trypanosoma cruzi, purification and composition of a glycoprotein. Comp Biochem Physiol 1983; 72B: 313.
• Subias, E., Yanovski, J., Alvarez, M. and Segura, E.L. Conservation of blood samples for epidemiological research on Chagas’ disease. J. Protozool. 1983; 30: 164.
• Cabeza Meckert PM, Cazzulo JJ, Segura EL, Esteva MI, Ruiz AM, Gelpi R, Laguens RP. Induction of heart alterations by immunization with subcellular fractions from Crithidia fasciculata . Experientia 1984; 40: 171-3.
• Bontempi E, Franke de Cazzulo BM, Ruiz AM, Cazzulo JJ. Purification and some properties of an acidic protease from epimastigotes of Trypanosoma cruzi, Comp Biochem Physiol. 1984; 77B(3):599-604.
• Cannata JJB, Cazzulo JJ. Glycosomal and mitochondrial malate dehydrogenases in epimastigotes of Trypanosoma cruzi. Mol Biochem Parasitol. 1984; 11:37-49.
• Cannata JJB, JJ Cazzulo. The aerobic fermentation of glucose by Trypanosoma cruzi. Comp Biochem Physiol. 1984; 79B: 297-308.
• Cardoni RL, De Titto EH, Docampo R. On the mechanism of killing of Trypanosoma cruzi by human polymorphonuclear leukocytes. Experientia. 1985; 41: 89-91.
• Cazzulo JJ. Protein and amino acid catabolism in Trypanosoma cruzi. Comp Biochem Physiol. 1984; 79B(3):309-20.
• Sanchez DO, Madrid R, Engel JC, Frasch ACC. Rapid identification of Trypanosoma cruzi isolates by «dot-spot» hybridization. FEBS Letters. 1984; 168: 139-42.
• Parodi AJ, Martin-Barrientos J, Engel JC. Glycoprotein assembly in Leishmania mexicana. Biochem Byophis Res Comm. 1984; 118: 1-7.
• Cardoni RL, De Titto EH, Docampo R. On the mechanism of killing of Trypanosoma cruzi by human polymorphonuclear leukocytes. Experientia. 1985; 41: 89-91.
• De Titto EH, Braun M, Lázzari JO, Segura EL. Cell mediated reactivity against human and Trypanosoma cruzi antigens according to clinical status in Chagas’disease patients. Immunol Letters. 1985; 9: 249-54.
• Segura EL, Perez AC, Yanovski JF, Andrade J, de Martini GJW. Decrease in the prevalence of infection by Trypanosoma cruzi (Chagas’ disease) in young men of Argentina. Bull Pan Am Health Org. 1985; 79: 252-64.
• Segura EL, González Cappa SM. Relación huésped-parásito en T. cruzi EN: Carcavallo RH, JE Rabinovich, RJ Tonn. Parásitos-reservorios-control-situación regional. Buenos Aires: Servicio Nacional de Chagas, ( Factores biológicos y ecológicos en la Enfermedad de Chagas. 1985; V2: 263-67.
• Ruiz AM, Wisnivesky-Colli C, Gürtler RE, Lázzari JO, Bujas MA, Segura EL. Infección por T. cruzi en humanos, perros y cabras en áreas rurales de la Provincia de Córdoba. Medicina (Buenos Aires) 1985; 45: 539-46.
• Wisnivesky-Colli C, Lauricella M, Solarz N, Bujas MA, Segura EL. Epidemiological role of humans, dogs and cats in the transmission of T. cruzi in a central area of Argentina. Rev Inst Med Trop S Paulo. 1985; 27: 346-52.
• Ruiz AM, Esteva MI, Cabeza Meckert P, Laguens RP, Segura EL. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi . Acta Tropica. 1985; 42: 299-309.
• Segura EL, Cazzulo JJ. Antigenic characterization of Trypanosoma cruzi. Rev Soc Brasil Med Trop. 1985; 18(Supl): 47-51.
• Orellano EG, Vallejos RH, Cazzulo JJ. Chemical modification of the active site of the NADP-linked glutamate dehydrogenase from Trypanosoma cruzi. Comp Biochem Physiol. 1985; 80B(3):563-8.
• Cazzulo JJ, Franke de Cazzulo BM. Pyruvate decarboxylase and alcohol dehydrogenase in the insect Trypanosomatid Crithidia fasciculata. Comp Biochem Physiol. 1985; 81B(4):1019-1022.
• Cazzulo JJ, Segura EL. Trypanosoma cruzi EN: Carcavallo RH, JE Rabinovich, RJ Tonn. Parásitos-reservorios-control-situación regional. Buenos Aires: Servicio Nacional de Chagas. (Factores biológicos y ecológicos en la Enfermedad de Chagas) 1985; V.2: 251-62.
• Cazzulo JJ, Franke de Cazzulo BM, Engel JC, Cannata JJB. End products and enzyme levels of aerobic glucose fermentation in Trypanosomatids. Mol Biochem Parasitol. 1985; 16: 329-343.
• De los Santos C, Buldain G, Frydman B, Cannata JJB, Cazzulo JJ. Carbon-13 nuclear magnetic resonance analysis of (I-13C)-glucose me abolism in Crithidiafasciculata. Evidence of CO2 fixation by phosphoenolpyruvate carboxykinas Eur J Biochem. 1985; 149(2): 421-9.
• Engel JC, Parodi AJ. Trypanosoma cruzi cells undergo an alteration in protein N-glycosylation upon differentiation. J Biol Chem. 1985; 260:105-10.
• Engel JC, Doyle PS, Dvorak JA. T. cruzi: Biogical characterization of clones derived from chronic Chagasic patients: II. Quantitative analysis of the intracellular cycle. J Protozool. 1985; 32(1):80-3.
• Macina R, Sanchez DO, Affranchino JL, Engel JC, Frasch ACC. Polymorphisms within homogeneous minicircle sequence classes in the kinetoplast DNA of Trypanosoma cruzi clones. Mol Biochem Parasitol. 1985; 16: 61-74.
• Stoka AM. Mecanismos endocrinos en la regulación del desarrollo de triatominos. EN: Carcavallo RH, JE Rabinovich, RJ Tonn. Epidemiología-vectores. Buenos Aires: Servicio Nacional de Chagas (Factores biológicos y ecológicos en la Enfermedad de Chagas) 1985; V.1: 103-12.
• Stoka AM, Salomón OD. Desarrollo y maduración de los ovocitos en triatominos. EN: Carcavallo RH, JE Rabinovich, RJ Tonn. Epidemiología-vectores. Buenos Aires: Servicio Nacional de Chagas (Factores biológicos y ecológicos en la Enfermedad de Chagas) 1986; V.1: 83-90.
• Ruiz AM, Esteva MI, Riarte A, Subias E, Segura EL. Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant. Immunol Letters. 1986; 12: 1-4.
• Segura EL, Bua J, de Campanini AR, Subias E, Esteva MI, Moreno M, Ruiz AM. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi : complement mediated lytic activity on trypomastigotes and passive immunoprotection in mice. Immunol Letters. 1986; 13: 165-71.
• Gürtler RE, Lauricella M, Solarz ND, Bujas MA, Wisnivesky C. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. Rev Inst Med Trop S Paulo. 1986; 28: 28-35.
• Gürtler RE, Solarz ND, Lauricella M, Haedo AS, Pietrokowski SM, Alberti AA, Wisnivesky C. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. III. Persistence of T. cruzi parasitemia among canine reservoirs in two-years follow up. Rev Inst Med Trop S Paulo. 1986; 28: 213-19.
• Lauricella M, Riarte A, Lázzari JO, Barousse AP, Segura EL. Enfermedad de Chagas en perros experimentalmente infectados con Trypanosoma cruzi. Medicina (Buenos Aires). 1986; 46: 195-200.
• Martin UO, Maidana CG, Fernandez H, de Marteleur A, Subias E. Anticuerpos específicos anti-Trypanosoma cruzi en niños con Enfermedad de Chagas aguda. Medicina (Buenos Aires). 1986; 46: 167-71.
• Affranchino JL, Sanchez DO, Engel JC, Frasch ACC, Stoppani AOM. Trypanosoma cruzi : structure and transcription of kinetoplast DNA maxicircles of cloned stocks. J Protozool. 1986; 33: 503-7.
• Salomon OD, Stoka A. Vitellin and vitellogenin characterization of Triatoma infestans and related species. Acta Physiol Pharmacol Latinoam. 1986; 36: 419-29.
• Cardoni RL, Rimoldi MT, Esteva MI, de Elizalde de Bracco MM. Humoral antibody response in mice infected with Trypanosoma cruzi . Medicina (Buenos Aires). 1986; 46: 435-9.
• Camargo M, Segura EL, Kagan I, Pacheco Souza J, da Rocha Carnalheiro J, Yanovsky J, Guimaraes MC. Three years of collaboration on the standarization of Chagas’ disease serodiagnosis in the American Continent. PAHO Bull. 1986; 20: 233-44.
• Segura EL, Pérez AC, Yanovsky JE, Andrade J, Wynne de Martini GJ. Disminución en la prevalencia de infección por Trypanosoma cruzi (Enfermedad de Chagas) en hombres jóvenes de la Argentina. Bol Ofic Sanit Panam. 1986; 100(5): 493-510.
• Camargo M, Segura EL, Kagan IG, Souza JMP, Carvalheiro JR, Yanovsky JF, Guimaraes MCS. Normalización del diagnóstico serológico de la E. de Chagas en las Américas: evaluación de tres años de colaboración, Bol Ofic Sanit Panam. 1986; 102(5):449-52.
• Carlomagno MA, Riarte A, Moreno M, Segura EL. Effects of calorie-restriction on the course of Trypanosoma cruzi infection. Nutr Res. 1987; 7: 1031-40.
• De Titto EH, Moreno M, Braun M, Segura EL. Chagas’ disease: humoral response to subcellular fractions of Trypanosoma cruzi in symptomatic and asymptomatic patients. Trop Med Parasitol. 1987; 38: 163-166.
• De Titto EH, Araujo FG Mechanism of cell invasion by trypanosoma cruzi: importance of sialidas activity. Acta Tropica. 1987; 44, 273-282.
• Morales MC, Cardoni RL, Rimoldi MT, Esteva MI, Milei J. Heart damage comparing three strains of mice chronically infected with Trypanosoma cruzi. Medicina (Buenos Aires) 1987; 47: 493-9.
• Nuñez J, Segura EL. Rearing of Triatominae bugs. In «Chagas’ disease vectors»(A Stoka Ed.) CRS Press. 1987; 2: 31-40.
• Segura EL. Xenodiagnosis. En «Chagas’ disease vectors” (A Stoka Ed.) CRS Press. 1987; 2: 41-5.
• Stoka AM. Ecdysteronds, juvenile hormones, and metamorphosis Triatominae. CRC Press. 1987; 3: 71-99.
• Stoka AM, Salomón OD, Noriega FG. Physiology od Triatominae’s reproduction Triatominae CRC Press. 1987; 2: 109-129.
• Stoka AM, Ronderos JR, Reboredo GR. Insect control by endocrine disorder. Triatominae CRC Press. 1987; 3:139-47.
• Wisnivesky Colli C, Paulone I, Perez AC, Gürtler R, Gualtieri J, Solarz N, Smith A, Segura EL. A new tool for continuous detection of the presence of triatomine bugs, vectors of Chagas’ disease, in rural households. Medicina (Buenos Aires) 1987; 47:45-50.
• Wisnivesky C, Ruiz AM, Ledesma O, Gurtler R, Lauricella M, Salomon D, Solarz N, Smith A, Segura EL. Ecología doméstica de la Trypanosomiasis Americana: perfil alimentario del Triatoma infestans en un área rural de la Provincia de Santiago del Estero, Argentina. Rev Soc Bras Med Trop. 1987; 20:31-9.
• Boullon F, Sinagra A, Riarte A, Lauricella M, Barra J, Besancon M, Lejour CH, Lopez Blanco O, Favaloro R, Segura EL. Experimentalcardiac transplant and chronic Chagas’disease in dogs. Transplant Proc. 1988; 20(Supl):432-7.
• Cardoni RL, Rottenberg ME, Segura EL. A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection. Parasitol Res. 1988; 74: 512-5.
• Paulone I, Chuit R, Perez A, Wisnivesky-Colli C, Segura EL. Field research on a epidemiological surveillance alternative of Chagas’disease transmission: the primary health care (PHC) strategy in rural areas. Rev Arg Microbiolog. 1988; 20 (Supl I):103-5.
• Rodriguez JB, Gros E, Stoka AM. Synthesis and activity of juvenile hormone analogues (JHA). Z Naturforsch. 1988; 43b:1038-42.
• Rodriguez JB, Gros E, Stoka AM. Synthesis and activity of juvenile hormone analogues (JHA): part II. Z Naturforsch. 1988; 44b: 983-7.
• Rottemberg ME, Cardoni RL, Andersson R, Segura EL, A Orn. Role of NK and T-helper inducer cell on the resistance to Trypanosoma cruzi infections. Scand J Inmunol. 1988; 28: 573-82.
• Rottenberg M, Cardoni RL, de Titto EH, Moreno M, Segura EL. Trypanosoma cruzi : immune response in mice immunized with parasite antigens. Exp Parasitol. 1988; 65:101-109.
• Stoka AM, Disruption of development on triatominae bugs by action of juvenile hormone analogues. Rev Arg Microbiol. 1988; 20 (Supl I):86-90.
• Ulloa RM, Mesri E, Esteva MI, Torres HN, Tellez-Iñon MT. Cyclic AMP-dependent protein kinase activity in Trypanosoma cruzi. Biochem J. 1988; 255:319-26.
• Wisnivesky-Colli C, Paulone I, Chuit R, Perez A, Segura EL. A new method for the detection of reinfested households during surveillance activities of control programmes of Chagas’disease. Rev Arg Microbiol.1988; 20 (Supl I):96-102.
• Segura EL, Ruiz AM, Analía Pérez y Stoka A. (1988). Preguntas y respuestas sobre la Enfermedad de Chagas. Segunda Ed. (Coordinación J. Raggi). Fundación Banco de Boston.
• Segura EL. Xenodiagnosis. In «Chagas’ disease vectors» (A Stoka Ed.) CRS Press. 1988; 2: 41-5.
• Bontempi E, Martinez J, Cazzulo JJ. Subcellular localization of a cysteine proteinase from Trypanosoma cruzi. Mol Biochem Parasitol. 1989; 33: 43-8.
• Lauricella M, Sinagra A, Paulone I, Riarte AR, Segura EL. Natural Trypanosoma cruzi infection in dogs of endemic areas of the Argentine Republic. Rev Inst Med Trop Sao Paulo. 1989; 31: 63-70.
• Levin MJ, Mesri E, Benarous R, Levitus G, Schijman A, Levi-Yeyati P, Chiale P, Ruiz AM, Kahn A, Rosenbaum MB, Torres HN, Segura EL. Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas´ heart disease. Am J Trop Med Hyg. 1989; 41(5): 538-8.
• Carlomagno, M.; Cura, E.; Pérez, A. and Segura, E.L. Informe sobre Chagas. Ciencia Hoy. 1989; 1(2), 36-44.
• Chuit R, Subias E, Perez AC, Paulone I, WIsnivesky-Colli C, Segura EL. Usefulness of serology for the evaluation of triatomid control campaing Trypanosoma cruzi transmission in endemic areas of Chagas’disease. Rev Soc Med Trop. 1989; 22(3):119-24.
• De Titto EH, Dasso M, Esteva M, Segura EL. Antígenos de Trypanosoma cruzi reconocidos por anticuerpos IgG en la forma crónica de la Enfermedad de Chagas. Medicina (Buenos Aires) 1989; 49; 468.
• Perez AC, Segura EL. Transfusión de sangre y transmisión de la infección Chagásica en la Argentina 1987. Rev Arg Transfusión. 1989; 15: 127-32.
• Rottemberg ME, Lindquist C, Koman A, Segura EL, Orn A. Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine T. cruzi infection. Scand J of Inmunol. 1989; 30: 65-72.
• Segura EL, Cardoni RL, Bua J, Rottemberg ME, Bontempi EJ, Esteva MI, Carlomagno MA, de Titto E, Ruiz AM. Bases Moleculares e inmunológicas para el desarrollo de una nueva vacuna contra la Enfemedad de Chagas. Medicina (Buenos Aires) 1989; 49:203-9.
• Stoka AM, Rivas C, Segura EL, Rodriguez JB, Gros E. Biological activity of synthetic juvenile hormone analogues (JHA) for T. cruzi Z Naturforsch. 1989; 45b: 96-98.
• Wisniveskt-Colli C., Ruiz AM., Gurtler R., Solarz N., Lazzari J., Ledesma O., Bujas MA., De Rissio AM., Segura EL. Dinamics of transmission od Trypanosoma cruzi in a rural area of Argentina. IV. Serologic, Parasitologic and Electrocardiographic study of the human population. Medicina (Buenos Aires) 1989; 49: 341-350.
• Sinagra, A.J.; Riarte, A.; Segura, E.L. Chagas murino e inmunosupresion. Su influencia en la evolución de la enfermedad. Medicina (Buenos Aires). 1989; 49, 467.
• de Titto, E.H.; Dasso, M.; Esteva, M.; Segura, E.L. Antígenos de Trypanosoma cruzi reconocidos por anticuerpos IgG en la forma crónica de la Enfermedad de Chagas. Medicina (Buenos Aires). 1989; 49, 467.

1990 – 1998

• Bontempi EJ, Cazzulo JJ. Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiolog. Letters. 1990; 70: 337-342.
• Bua J, Bontempi EJ, Ruiz AM, Segura EL. Antígenos en Tripanosoma cruzi. Rev Arg Microbiol. 1990; 22: 47-66.
• Cardoni RL, Rottenberg ME, Segura EL. Increased production of reactive oxygen species by cells from mice acutely infected with T. cruzi. Cell Inmunol. 1990; 128:11-21.
• Kaleab B, Ottenhoff T, Converse P, Halapi E, Tadese G, Rottemberg M, Kiessling R. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Inmunol. 1990; 20: 2651-9.
• Ouaissi MA, Taibi A, Cornette J, Velge P, Marty R, Loyens M, Esteva M, Rizvi FS, Capron A. Characterization of major surface and excretory-secretory inmunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen. Parasitol. 1990; 100:115-24.
• Perez AC, Cura E, Subias E, Lansetti JC, Segura EL. Long-term preservation of blood samples for diagnosis of Trypanosoma cruzi infection. Trop Med. 1990; 41:75-6.
• Rottemberg ME, Cardoni RJ, Segura EL. Involvement of L374+, LYT2.2+ T cell subsets and non-T cells in the resistance of mice against Trypanosoma cruzi infection. Inter J Parasitol. 1990; 20(3):397-400.
• Rabinovich JE, Wisnivesky-Colli C, Solarz N, GurtlerR. Probability of transmission of Chagas disease by Triatoma infestans (Hemiptera: Reduviidae) in an endemic area of Santiago del Estero, Argentina. Bull World Health Organ. 1990; 68(6): 737-46.
• Ruiz AM, Esteva MI, Subias E, Moreno M, de Campanini AR, Velazquez E, Segura EL. Monoclonal antibodies against the flagellar fraction of epimastigote of T. cruzi. II Inmunoprotection against metacyclic trypomastigotes obtained by inmunization of mice with an affinity purified antigen. Mol Biochem Parasitol. 1990; 30:117-26.
• Segura EL y Ruiz AM. Enfermedad de Chagas o Tripanosomiasis Americana. En Compendio de Parasitosis humanas producidas por protozoos. Enfermedad de Chagas, Leishmaniasis, Malaria y Toxoplasmosis. Ed. Carlomagno et. al. Instituto Nacional de Chagas Dr. Mario Fatala Chabén. Buenos Aires, Argentina, 1990
• Rottenberg ME., Cardoni .L. and Segura EL. Involvement of L3T4+, Lyt 2.2+ T cell subsets and non-T cell in the resistance of mice against Trypanosoma cruzi infection. Int. Parasitol. 1990; 20: 397-400.
• Búa J, Bontempi E, Ruiz AM. y Segura, EL. Actualización en antígenos de T. cruzi.Rev. Arg. Microb. 1990; 22, 47-66.
• Aulet F, Riarte A, Pattin M, Segura EL, Vazquez M. Chagas disease and kidney transplantation. Transplanting Proceedings. 1991; 23(5): 2653.
• Bua JE, Bontempi EJ, Levin M, Orn A, Velazco D, Moreno M, Levi-Yeyati P, Engstrom A, Segura EL, Ruiz AM. Trypanosoma cruzi: cellular and antibody response against the parasite in mice inmunized with a 19-Amino acid synthetic peptide. Exp Parasitol. 1991; 72: 54-62.
• Carlomagno MA, Riarte AR, Segura EL. Effects of renuttrition on caloric-deficient mice during T. cruzi infection. Nutr Res. 1991; 11: 1285-91.
• Fichera L, Salomón D, Stoka A. Structures properties and inmunological identity of vitelin isolated from triatominae species. Acta Physiol Pharmac Latinoam. 1991; 41(4): 405-15.
• Gürtler RE, Cécere MC, Rubel DN, Petersen RM, Schweigmann NJ, Lauricella MA, Bujas MA, Segura EL, Wisnivesky-Colli C. Chagas disease in north-west Argentina infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans. Roy. Soc. Trop. Med. Hyg. 1991; 85: 741-745.
• Paulone I, Segura EL. The status of transmission of Trypanosoma cruzi in an endemic area of Argentina prior to control attempts. Ann Trop Med Parasitol. 1991; 85(5): 489-97.
• Rodriguez JR, Gros E, Stoka AM. Synthesis and biological activity of juvenile hormone (JHA) for T. cruzi. Biorganic and medicinal Chemistry Letters. 1991; V1 (12):679-682.
• Rottemberg ME, Cardoni RL, Sinagra A, Riarte A, Rodriguez Nantes I, Lauricella M, Segura El. Trypanosoma cruzi: T-cell-dependent mechanism of resistance during chronic infection. Exper Parasitol. 1991; 73:127-36.
• Rottemberg ME, de Titto E, Cardoni R, Segura EL. Respuesta inmune en la infección con T. cruzi. Rev. Arg. Microbiol. 1991; 23: 101-121.
• Sanz OP, Cardoni RL, Celentano AM, Rimoldi MT, Sica RE, González Cappa SM. Trypanosoma cruzi: induction of changes in the peripheral nervous system in differents strains of mice. Rev Argent Microbiolog. 1991; 23: 30-4.
• Campanini A, Subias E, Esteva M, Ruiz AM y Segura EL. Anticuerpos Monoclonales contra T.cruzi. en Actualizaciones en Inmunología Básica y Aplicada I. Editores: Mazolli A, Barrera C, Giraudo Conesa L, Bonaparte V de y Nejankis M. Buenos Aires, Argentina, 1991; pp 97-98.
• Dasso MC, de Titto EH. Electrophoretic analysis of Trypanosoma cruzi proteins. An Asoc Quim Argent. 1992; 80(1-3): 293-304.
• Fichera LE, Riarte A. Embryology of Triatoma infestans (Klug) (Hemiptera, Reduviidae), a Chagas disease vector. Rev Inst Med Trop S Paulo. 1992; 34: 211-6.
• Forniciari G., Castagna M., Viacava P., Tognetti A., Esteva M., Segura EL. Bevilacqua, G Malattia di Chagas in una mummia peruviana Inca del Museo Nazionale di Antropologia ed Etnologia di Firenze. Archivio per 1 Antropologia e la Etnologia. 1992; 122: 369-376.
• Gorelik G., Borda E., Postan M., Gonzalez Cappa SM. T lymphosites from Trypanosoma cruzi infected mice alter heart contractility: participation of arachidonic acid me abolites. J. Mol. Cardiol. 1992; 24: 9-20.
• Porcel BM, Bua J, Esteva MI, Bontempi E, Segura EL, Ruiz AM. Obtención de una proteína recombinante inmunogénica en ratones BALB/c semejante al antígeno 1 de 43 KDa. presente en la superficie del Trypanosoma cruzi. An Asoc Quim Argent. 1992; 80 (1-3): 271-83.
• Segura EL., Ruiz AM. Trypanosoma cruzi. En Enfermedades Infecciosas y Microbiología Clínica. Ed Perea EJ, Edic. DOYMA, Madrid, España. 1992; Cap. 82: 989-994.
• Slimovich R, Rivas C, Velázquez EV, Ruiz AM, Segura EL. Anticuerpos monoclonales anti Leishmania brasiliensis: desarrollo de un ensayo de inmunocompetición y análisis de sueros con reactividad cruzada entre Lehismania Trypanosoma cruzi. An Asoc Quim Argent. 1992; 80 (1-3): 285-92.
• Tarleton RL., Koller BH., Latour A., Postan M. Susceptibility of beta-2-microblobulin deficient (MHC class I-negativ, CD8) mice to Trypanosoma cruzi infection. Nature. 1992; 356 (6367): 338-340.
• Zwirner NW., Malchioldi EL., Chiaramonte MG., Margni RA., Esteva MI., Fossati CA. Caracterización de un antígeno de Trypanosoma cruzi purificado con anticuerpos monoclonales. Utilidad diagnóstica y análisis de su immunogenicidad. Immunología. 1992; 4:120-127.
• Bontempi EJ, Bua J, Aslund L, Porcel B, Henriksson J, Din A, Segura EL, Pettersson U, Ruiz AM. Isolation and characterization of a gene from Trypanosoma cruzi encoding a 46-kilodalton protein with homology to human and rat tyrosine aminotransferase. Mol. Biochem. Parasitol. 1993; (59):253-262.
• Chuit R, Paulone I, Wisnivesky-Colli C, Bo R, Pérez AC, Sosa Estani S, Segura EL. Results of a first step toward community-based survillance of transmission of Chagas disease with appropiate technology in rural areas. AM. J. Trop. Med. Hyg. 1993; 46(4): 444-450.
• Lauricella MA, Wisnivesky -Colli C, Gurtler R, Pettersen R, Bujas M, Segura EL. Standarization of serological test for detecting anti- Trypanosoma cruzi in dogs. Mem. Inst. Oswaldo Cruz. 1993; 88(3): 413-417.
• Ruiz AM, Bua J. y Segura EL, Antígenos del Trypanosoma cruzi: Perspectivas futuras. In Enfermedad de Chagas. Ed Storino R, Milei J, Edic. DOYMA, Madrid, España. 1993; Cap. 32: 629-640.
• Segura EL, Esquivel ML, Sosa Estani S, Chuit R. Control de la Enfermedad de Chagas en Argentina. PAMI Científico. 1993; 8:11-26.
• Sinagra A, Riarte A, Lauricella MA, Segura EL. Reactivation of experimental chronic Trypanosoma cruzi infection following immunosuppresive treatment by Cyclosporina and betametasona. Transplantation 1993; 55(6):1434-1434.
• Sosa Estani S, Velazquez E, Segura EL, Yampotis C, Yelamos M, Albornoz P, Medina L. Quimioterapia en niños en fase indeterminada reciente de enfermedad de Chagas. Medicina (Buenos Aires) 1993; 53 Supl.I: 20-21.
• Vázquez MC; Zala C.; Alvarez F, Campanini A, Segura EL, Riarte, A. Evolución de pacientes chagásicos trasplantados renales. Nefrologia XIII. 1993; (2): 57-58.
• Cura E, de Titto E, Segura EL. El diagnóstico y su control de calidad en la infección por Trypanosoma cruzi. En: Actualización en Enfermedad de Chagas. Ed. Roberto Madoeri, Christian Madoeri y Mario I. Cámera. Organización Congreso Nacional de Medicina. 1993. PAG?
• Rosenstein-Campanini A, Blanco S.B, De Rissio AM., Lansseti J.C., Lauricela M., Segura EL. Transmisión de Trypanosoma cruzi por transfusiones de sangre. En Actualización en Enfermedad de Chagas. Ed.: Roberto Madoeri, Christian Madoeri y Mario Cámera. Organización Congreso Nacional de Medicina. 1993; pp. 237-242.
• Bontempi EJ, Porcel BM, Henriksson J, Carlsson L, Rydaker M, Segura EL, Ruiz AM, Pettersson U, Genes for histone H3 in Trypanosoma cruzi. Mol. Biochem. Parasitol. 1994; 66:147-151.
• Cardoni RL. Alteraciones de la respuesta inmune en la infección aguda con Trypanosoma cruzi. Revisión. En «Enfermedad de Chagas». Ed. Ed Storino R, Milei J, Edic. DOYMA; Mosby/Doyma. Argentina, Buenos Aires. 1994; cap 7: 87-102.
• De Titto E. Bases genéticas de la Enfermedad de Chagas. En «Enfermedad de Chagas». Ed. R Storino R y Milei J. Mosby/Doyma. Argentina, Buenos Aires 1994; cap 6: 75-86.
• Esquivel ML. y Segura EL. Estimación del número de infectados chagásicos en Argentina, Medicina (Buenos Aires) 1994; 54:(1) 91-2.
• Postan M., Correa R., Ferrans V. and Tarleton RL. In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Internat. Arch. Allergy Immunol. 1994; 105: 251-257.
• Salomón D. Presencia de Lutzomyia punctigeniculata (Floch et Abonnec) (Diptera:Psychodidae) en la República Argentina. Rev. Soc. Entomológica Argentina. 1994; 53: 1-4.
• Segura, E. L.; Esquivel, M. L.; Salomón, D.; Gómez, A.; Sosa Estani, S.; Luna, C. A.; Tulián, L.; Hurvitz, A.; Blanco, S.; Andrés, A.; Zárate, J.; Chuit, R. Participación comunitaria en el Programa Nacional de Control de la Transmisión de la Enfermedad de Chagas. Medicina (Buenos Aires). 1994; 54 (Nº 5/2): 610-611.
• Tarleton RL, Sun J, Zhang L, Postan M. Depletion of T-cell subpopulation results in exacerbation of myocarditis and parasitism in experimental Chagas disease. Infect. Immun. 1994; 62:1820-1829.
• Segura,E., Esquivel, M., Salomón, O., Sosa Estani, S., Gómez, A., Ibarra, F., Chuit, R. Alternativas de Control de la transmisión de Trypanosoma cruzi, en “Enfermedad de Chagas” Ed. R Storino R y Milei J. Mosby/Doyma. Argentina, Buenos Aires 1994, 641-648.
• Viotti R, Virgiliano C, Armenti H, Segura EL, Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. J. Heart. 1994; 127 (1): 151-161.
• Mangone, C. A.; Sica, R. E. P.; Pereyra, S.; Genovese, O.; Segura, E.; Riarte, A.; Sanz, O. P.; Segura, M. Cognitive impairment in human chronic Chagas’ disease. Arq. Neuropsiquiatr. 1994; 52 (2): 200-203.
• Segura EL, Esquivel ML, Salomón OD, Gómez AO, Luna CA y Sosa Están S. Control y Vigilancia de la Transmisión de Chagas con Participación Comunitaria utilizando Tecnología Apropiada: Manual para Supervisores. INDIECH. 1994.
• Segura EL, Esquivel ML, Salomón OD, Gómez AO, Luna CA y Sosa Están S Control y Vigilancia de la Transmisión de Chagas con Participación Comunitaria utilizando Tecnología Apropiada: Manual para Líderes. INDIECH. 1994.
• Ruiz, A. Búa, J., Segura, E.L. Antígenos del Trypanosoma cruzi: Perspectivas futuras, en “Enfermedad de Chagas”, Storino R. y Milei J. Ed Mosby/Doyma. Argentina, Buenos Aires 1994; pp.629-640.
• Fichera L, Esteva MI, Wimmer Z, Rodríguez JB and Gros EG. Effects of juvenile Hormone Anologues (JHA) on the Development of Tripanosoma cruzi. Z. Naturforch 1995; 50: 578-580.
• Henriksson J, Porcel B, Rydlker M, Ruiz AM, Cazzulo JJ, Frasch AC and Pettersson U. Trypanosoma cruzi genome project: Chromosome-specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation. Mol. Biochem. Parasitol.1995; 73: 63-74.
• Jazin EE, Bontempi E, Sanchez DO, Aslund L, Henriksson J, Frasch ASCC, Pettersson U. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family. Parasitology. 1995; 110: 61-69.
• Montemartini M, Bua J, Bontempi EJ, Zelada C, Ruiz AM, Santome JA, Cazzulo JJ and Nowickii C. A recombinant Tyrosine aminotransferase from Trypanosoma cruzi has both, Tyrosine Aminotransferase and Alanine Aminotransferase activities. FEMS Microbiol letters. 1995; 133:17-20.
• Paveto C, Pereira C, Espinoza J, Montagna A, Farver M, Esteva. M, Flawiá M. and Torres H. The nitric oxide transduction parthway in Trypanosoma cruzi. The Journal of Biological Chemistry. 1995; 270 (8): 16576-9.
• Riarte A, Sinagra A, Lauricella MA, Bolomo N, Moreno M, Cossio P. and Segura EL. Chronic Experimental Infection by Trypanosoma cruzi in Cebus apella monkeys. Memorias Do Instituto Oswaldo Cruz. 1995; 90: 1-4.
• Rottemberg M, Riarte AR, Sporrong L, Altech J, Petray P, Ruiz AM, Wigzell H. and Orn A. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Inmunology Letters. 1995; 45: 53-60.
• Schavartzapel A, Fichera L, Esteva MI, Rodríguez JB. and Gros EG. Desing, Synthesis and anti T. cruzi evaluation of a new class of cell-grawth inhibitors structuralyl related to fenoxycarb. Helvetica Chimica Acta. 1995; 78: 1207-1214.
• Segura, EL, Esquivel, ML, Estimación del número de infectados chagásicos en la Argentina. Medicina (Buenos Aires) 1995; 55(2): 186-188.
• Cardoni R, Antunez MI, Orn A, Gronvik KO. T Cell Receptor Vb Repertoire in the Thymus and Spleen of Mice Infected with Tripanosoma cruzi. Cellular Inmunology. 1996; 169: 238-245.
• Carlomagno M, Leer G, Esteva MI, Hansen D. and Segura EL. Role of Protein Deficiency on the Course of Trypanosoma cruzi Infection and on the Degree of Protection Conferred by a Flagellar Fraction. J. Nut. Immunol. 1996; 4:37-45.
• Carlomagno M, Hansen DS, Villacres-Erickson M, Akerblom L Hellman U, Segura EL and Morein B. Immune suppression by Trypanosoma cruzi antigens identified by monoclonal antibodies prepared with T. cruzi iscoms. In New Dimensions in Parasitology. Acta Parasitológica Técnica. Chapter. 1996; 8: 63-69.
• Enría D.; Padula, P.; Segura, E.L.; Pini, N.; Edelstein, A.; Riva Posse, C.; Weissenbacher, M.C. Hantavirus Pulmonary Syndrome in Argentina. Possibility of person to person transmission. Medicina (Buenos Aires). 1996; 56, 709-711.
• Gürtler RE., Cecere MC, Castañera MB, Canale D, Lauricella M.A, Chuit R.; CohenJ.E. and Segura EL. Probability of infection with Trypanosoma cruzi of the vector Triatoma infestans fed on infected humans and dogs in northwest Argentina. Am. J.Trop. Med. Hyg. 1996; 55 (1): 24-31.
• Genovese O, Ballario C, Storino R, Segura EL and Sica RE. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr. 1996 Jun; 54(2): 190-6.
• Hansen DS, Allievi G, Segura EL, Carlomagno M, Morein B and Villacrés-Eriksson M. The flagellar fraction of Trypanosoma cruzi depleted of an immunosuppresive antigen enhances protection to infection and elicits spontaneous T cell responses. Parasite Immunol. 1996; 18: 607-615.
• Laucella S, Salcedo R, Castaños Velez E, Riarte A, De Titto E, Patarroyo M, Orn A & Rottenberg M. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunology. 1996; 18: 227-139.
• Laucella SA, ME Rottenberg and De Titto EH. Papel de las citoquinas en la resistencia y patología durante la infección con Trypanosoma cruzi. Revista Argentina de Microbiología. 1996; 28: 99-109.
• Laucella SA, de Titto EH and Segura EL. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by natural antibodies: prognosis value in Chagas´disease. Acta Tropica. 1996; 62: 151-162.
• Laucella SA, de Titto EH, Segura EL, Orn A and Rottenberg ME. Soluble cell adhesion molecules in human Chagas´ disease: Association with disease severety and stage of infection. Am. J. Trop. Med. Hyg. 1996; 55: 629-634.
• Laucella S, Velazquez E, Dasso M, De Titto E. Trypanosoma cruzi and mammalian heart cross-reactive antigens. Acta Tropica. 1996; 61: 223-238.
• Laucella S.A., E.H. de Titto, E. L. Segura, A. Orn, M.E. Rottenberg, Soluble cell adhesion molecules in human Chagas´disease: association with disease severity and stage of infection. Am. J. Trop. Med. Hyg. 1996; 55 (6): 629-634.
• Porcel BM, Bontempi EJ, Henriksson J, Rydaker M, Aslund L, Segura EL, Pettersson U, Ruiz AM. Trypanosoma rangeli and Trypanosoma cruzi: Molecular Characterization of Genes Encoding putative Calcium-Binding Proteins, Highly Conserved in Trypanosomatids. Exp.Parasitol. 1996; 84: 387-399
• Stoka AM. Activity of Juvenile Hormone Analogues on the growth of trypanosoma cruzi, Steroid Biochem. Mole. Biol. 1996; Vol 59 No 5/6: 495-500.
• Tarleton RL, Grusby MJ, Postan M & Glimsher LH. Trypanosoma cruzi infection in MHC deficient mice: further evidence for the role of both class I and class II restricted T cells in immune resistance and disease. International lmmunology. 1996; 8:13-22.
• Tarleton RL, Nunez M, Zhang L, Heighs M, Postan M. Cytotoxic T cells as potential vaccine candidates for Trypanosoma cruzi infection. En: New Dimensions in Parasitology. Ed. Ali Ozcel, Ege University Publishing Office, Bornova, Turkey. 1996: 71-78.
• Weissenbacher M., Cura E.N, Segura E.L., Hortal M., Baek, L.J., Chu Y.K., Lee H.W. Serological evidence of human Hantavirus Infection in Argentia. Bolivia and Uruguay. Medicina (Buenos Aires), 1996; 56: 17-22.
• Antúnez MI, Feinstein R, Cardoni RL and Grönvik K-O. T. cruzi. T cell populations in the Peyer’s patches of BALB/c infected mice. Exp. Parasitology. 1997; 87: 58-64.
• Antúnez MI, Cardoni RL. Superantígenos: una particular interacción entre microrganismos y el sistema inmune. Medicina (Buenos Aires) 1997; 57: 608-616.
• Calderón G, Addlestein A, Enria D. González de La Valle M, Levi S, Martínez V, Miguel S, Padula P, Pini N, Segura EL, Sosa Estani S, Weissenbacher MC, Yadón Z. Manual de procedimientos para la atención y control de la transmisión de Hantavirus que produce Sindrome Pulmonar, Diciembre de 1997 (3ra Edición).
• Cardoni R. La respuesta inflamatoria en la infección aguda con Trypanosoma cruzi. Medicina (Buenos Aires) 1997; 57: 227-234.
• Cardoni R, Antunez M, Morales C, Rodriguez Nantes I. Release of reactive oxygen species by Phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am.J. Trop. Med. Hyg. 1997; 56(2): 329-334.
• Esquivel ML, Sosa Estani S, Segura EL, Análisis económico de programas de control: Costos y asignación de recursos, Medicina (Buenos Aires). 1997; 55 (Supl. III): 28-29.
• FicheraLE, Gomez A, Sosa Estani S, Segura EL. La estrategia de la participación comunitaria con tecnología apropiada para el control de la transmisión de la enfermedad de Chagas. Acta Toxicol. Arg. 5 (1) 15-62.
• Garg N, Postan M, Mensa-Wilmot K, Tarleton RL. Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. lnfection lmmunity. 1997; 65: 4055-4060.
• Imaz MS, Esteva M, Velázquez E, Ruiz AM, Segura EL, Marcipar, A. 1997. Inhibition of trypomastigotes infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi. Rev. Latinoam. Microbiol. 1997; 39(1-2): 33-46.
• Silber A, Búa J, Porcel B, Segura EL, Ruiz AM. Trypanosoma cruzi: Specific Detection of Parasites by PCR in Infected Human and Vectors Using a Set of Primers (BP1/BP2) Targeted to a Nuclear DNA Sequence. Exp.Parasitol. 1997; 85: 225-232.
• Sinagra A, Riarte A, Luna C, Campanini A, Segura EL. Leishmania (VianniaBraziliensis): Biological Behavior of Isolates from Argentina Patients, in golden hamsters. Am.J. Trop. Med. Hyg. 1997; 57(2): 115-118.
• Zingales B, Rondinelli E, Degrave W, Da Silveira J, Levin M, Le Paslier D, Modabber F, Dobrokhotov B, Swindle J, Kelly J, Aslund L, Hoheisel JD, Ruiz A., Cazzulo JJ, Pettersson U. and Frasch AC. The Trypanosoma cruzi genome initiative. Parasitology Today. 1997; Vol.13 (1): 16-22.
• Carriazo SC, Sembaj A, Aguerri AM, Requena JM, Alonso C, Bua J, Ruiz AM, Segura EL and Barral JM. Polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients. Diag. Microbiology and Inf. Disease. 1998; 30 (3): 183-186..
• Cura EN and Segura, EL. Quality assurance of the serological diagnosis of Chagas disease. Am. J. of Public Health. 1998; 3 (4): 242-248.
• Dictar M, Sinagra A, Verón MT, Luna C, Dengra C, De Rissio A, Bayo R, Ceraso D, Segura E, Koziner B, Riarte A. Recipients and donors of bone marrow transplants affected by Chagas disease: management and preemptive therapy of parasitemia. Bone Marrow Transplantation. 1998; 21: 391-393.
• Franke de Cazzulo BM, Bernacchi A, Esteva MI, Ruiz AM, Castro JA and Cazzulo JJ. Trypanocidal effect of SKF525A; Proadifen on different developmental forms of Trypanosoma cruzi. Medicina (Buenos .Aires). 1998; 58(4): 415-8.
• Franke de Cazzulo BM; Bernacchi A; Esteva M; Ruiz AM; Castro JA; and Cazzulo JJ. Trypanocidal effect of -diethylaminoethyl-diphenylpropylacetate hydrochloride (SKF 52SA; Proadifen) on different developmental foms of Trypanosoma cruzi. Medicina (Buenos Aires) 1998; 58: 415-418.
• Gürtler R. E., Cohen J. E., Lauricella M. A., Chuit R., y Segura E. L. Influence of humans and domestic animals on the household prevalence and density of Triatoma infestans populations in northwest Argentina. Am. J. of Trop. Med. Hyg. 1998; 58: 748-758.
• Hansen DS, Villacrés-Eriksson M, Akerbiom L, Hellman U, Segura EL, Carlomagno M and Morein B An inmunoaffinity purified Trypanosoma cruzi antigen suppresses antigen specific and mitogen-mediated cellular proliferation through a TGF-B Mediated Mechanism. Scand. J. Inmunol. 1998; 47: 509-516.
• Martin M, Arcavi M, Santillan G, Amendoeira MR, de Souza Neves E, Griemberg G, Guarnera E, Garberi JC and Angel S. Detection of human toxopiasma-specific immunogiobulins A, M and G with a recombinat Toxoplasma gondii roP 2 protein Clinical and Diagnostic Laboratory lmmunology. 1998; Sep: 627-631.
• Sosa Estani S, Segura EL, Ruiz AM, Velázquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with Benznidazole in children in indeterminate phase of Chagas disease. Am. J. Trop. Med. Hyg. 1998; 59(6): 526-529.
• Sosa Estani S, Campanini A, Sinagra A, Luna C, Peralta M, Coutada V, Medina L, Riarte A, Salomón D, Gómez A y Segura EL. Características Clínicas y Diagnóstico de la Leishmaniasis Mucocutánea en Pacientes de un Area Endémica de Salta, Medicina (Buenos Aires). 1998; 58: 685-691.
• Sterin-Borda L, Gorelic G, Postan M, Gonzalez Cappa SM, Borda E. Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulatin beta-adrenoreceptor autoantibodies. Cardiovascular Research 1998; 41, 116-125.

1999 – 2006

• Altclas J, Sinagra A, Jaimovich G, Salgueira C, Luna C, Requejo A, Milovic V, De Rissio AM, Feldman L, Riarte A. Reactivation of chronic Chagas’ disease following allogenic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Tranpl Infectious Disease. 1999; 1: 135-137.
• Bucio MI, Cabrera M, Segura EL, Zenteno E, Salazar-Schettino M. Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi. Immunol Invest. 1999; 28(4): 257-68.
• Búa J, García GA, Galindo M, Galanti N. y Ruíz AM. Correlación entre el mapa transcripcional y el cariotipo. Caracterización molecular de un antígeno de superficie de la familia Tc13. Medicina (Buenos Aires.) 1999; 59(Supl.II): 11-17.
• Calderón G, Pini N, Bolpe J, Levis S, Mills J, Segura E, Gutmann N, Cantoni G, Becker J, Fonollat a, Ripoll C, Bortman M, Benedetti, Sabattini M and Enria D., Hantavirus reservoir hosts associated with peridomestic habitats in Argentina, Emerging Infectious Diseases. 1999; 5: 792-797.
• Cardoni RL, Antúnez MI y Abrami AA. La respuesta TH1 en la infección experimental con T. cruzi. Medicina (Buenos Aires). 1999; 59 (Supl II): 84-90.
• De Rissio AM. “Infección por Trypanosoma cruzi - Tamizaje en Bancos de Sangre. “Diagnóstico de Infección por Trypanosoma cruzi-Normativas”. Cuadernillo del Programa de Educación a Distancia en Sangre y Componentes de la Sangre Seguros. Asociación Argentina de Hemoterapia e Inmunohematología AAHI. Inegrantes del Programa AAHI, Ministerio de Salud, ANLIS, OPS/OMS. Septiembre de 1999; Capítulo 2.
• Freilij H; Mariani G; De Rissio AM; Alvarez M; Riarte A; Higa M; Pennisi A; Bulstein D; Ortiz de Zárate M; Angel S; Guarnera E; Fritsches C; Hirt J. Coordinadores : Altcheh J y Moreno R. “Consenso de Infecciones Perinatales” - Infecciones Perinatales Parasitarias Toxoplasmosis y Chagas. Revista Archivos Argentinos de Pediatría. 1999; Vol 97 Nº 3 : 178-187.
• Okuda K, Esteva M, Segura EL, Bijovsky AT. The cytostome of Trypanosoma cruzi epimastigotes is associated to the flagellar complex. Exp. Parasitol. 1999; 92: 223-231.
• Blanco SB, Segura EL, Gürtler RE, El control de la transmisión congénita de Trypanosoma cruzi en la Argentina. Medicina (Buenos Aires). 1999; 59 (Supl. II): 138-142.
• Laucella, SA, Segura EL, Riarte A, Sosa Estani S. Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas’ disease. Clin. Exp. Immunol. 1999; 118: 423-427.
• Postan M, Arnaiz M y Fichera L. Respuesta de células musculares cardíacas a la infección experimental por T. cruzi. Medicina (Buenos Aires). 1999; 59 (Supl II):57-62.
• Riarte A, Luna C, Sabatiello R, Sinagra A, Schíavelli R, De Rissio AM, Maiolo E, Martín Garcia M, Jacob N, Pattin M, Lauricella M, Segura EL & Vázquez M. Chagas disease in patients with kídney transpiants: a 7 years of experience, 1989-1996. Clin & lnf Dis. 1999; 29(3): 561-7.
• Sterin-Borda L, Gorelic G, Postan M. Gonzalez Cappa SM, Borda E. Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoreceptor-related autoantibodies. Cardiovascular Research, 1999; 41:116-125.
• Segura EL. et al. Control de la transmisión de Trypanosoma cruzi en la Argentina. Medicina (Buenos Aires) 1999; 59 (Supl.II): 91-96.
• Sosa Estani S, Segura EL. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz. 1999; Sep; 94 Suppl 1: 363-365.
• Segura EL, Sosa Estani S, Esquivel ML, Gómez A, Salomón OD y Grupo de Desarrollo y Aplicación Operativa, Control de la Transmisión de Trypanosoma cruzi en la Argentina 1999. Medicina (Buenos Aires). 1999; 59(Supl II): 91-96.
• Sosa Estani S y Segura EL. Tratamiento de la infección por Trypanosoma cruzi en fase indeterminada. Experiencia y normatización actual en la Argentina. Medicina (Buenos Aires). 1999; 59 (Supl. II): 166-170.
• Segura EL. Reforzamiento de los laboratorios de Salud y su integración en Redes de Laboratorios de salud de la Argentina, 1999. Medicina (Buenos Aires). 1999; 59 (Supl. III): 2-6.
• Blanco SB, Segura EL, Cura EN, Chuit R., Tulian L, Flores I, Garbarino G, Villalonga JF, Gurtler RE. Congenital transmisión of Trypanosoma cruzi an operational outline for detecting and treating infecyed infants in northwestern Argentina. Trop. Med. and Int. Health.2000; 5(4): 293-301.
• Sequeira A, Molina V, Monfellano M, Bolpe J, Guarnera E. Genetic diver sity among isolates of Trichinella spiralis from the province of Buenos Aires (Argentine) assessed through RAPDs. Journal of Helmintology. 2000; 74: 277-282.
• Pszenny V, Angel SO, Duschak VG, Paulino M, Ledesma V, Yabo MI, Guarnera E, Ruiz AM, Bontempi EJ. Molecular cloning, sequencing and expression of a serine proteinase inhibitor gene from Toxoplasma gondii. Mol. Biochem. Parasitol. 2000; 107: 241-249.
• Antunez MI, Cardoni RL. IL-12 and IFNg production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Inmunol Letters. 2000; 71: 103-109.
• Kamenetzky L, Canova SG, Guarnera E, and Rosenzvit MC. Echinococcus granulosus: DNA extraction from germinal layers allows strain determination in fertile and nonfertile hydatid cysts. Exp.Parasitol. 2000; 95: 122-127.
• Rojas PA, Martin V, Nigro M, Echeverría PC, Guarnera E, Pszenny V, Angel S. Expression of a DNA encoding a Toxoplasma gondii protein belonging to the heat-shock 90 family and analysis of its antigenicity. Microbiology Letters. 2000; 190: 209-213.
• Padula PJ, Rossi CM, Della Valle MO, Martinez PV, Colavecchia SB, Edelstein A,Miguel SD, Rabinovich RD, Segura EL. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol. 2000; 49(2); 149-55.
• Bontempi EJ, García GA, Buschiazzo A, Henriksson J, Ruiz AM, Pettersson U, Pszenny V.The tyrosine aminotransferase from Trypanosomarangeli: sequence and genomic characterization. FEMS Microbiology Letters. 2000; 189: 253-257.
• Gaddi E, Laucella SA, Balbaryski J, Cantisano C, Barboni G, Candi M, Giraudi V. Prognositic value od soluble intercellular adhesion molecule-1 (s-ICAM-1) in HIV-infected children. Scand. J. Immunol. 2000; 52: 1-8.
• Segura EL, Juan N,Piquin ALM, Cuba Cuba CA, Abramo Orrego L, Mc Mahon-Pratt D, Montamat EE, Hooman Momen, Grimaldi G Jr., Molecular and Biological Characterization of Leishmania parasites implicated in an epidemic outbreak in northwestern Argentina. Parasitol Res.2000; 86: 504-8.
• Segura EL, Cura E, Sosa Estani S, Andrade J, Lansetti JC, De Rissio AM, Campanini A, Blanco S, Gurtler E, Alvarez M. Long–Term effects of a nationwide control program on the seropositivity for Trypanosoma cruzi infection in young men from Argentina, Am. J. Trop. Med. Hyg. 2000; 62(3): 353-362.
• Sosa-Estani S, Segura EL, Salomon OD, Gomez A, Peralta M, Coutada V, Ruiz LM. Tegumentary leishmaniasis in Northern Argentina: distribution of infection and disease, in three municipalities of Salta, 1990-1992. Rev. Soc. Brasileira. Med. Trop. 2000; 33(6): 573-82.
• Schmunis GA, Zicker F, Segura EL, del Pozo AE. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion. 2000; 40 (9): 1048-53.
• Sosa-Estani S, Salomon OD, Gomez AO, Esquivel ML, Segura EL. Regional differences and Hantavirus pulmonary syndrome. Cad Saude Publica. 2000; 17 Suppl:47-57.
• Guarnera E, Santillán G, Botinelli R, Franco A. Canine Echinococcosis: an alternative for surveillance epidemiology. Veterinary Parasitology. 2000; 88:131-134.
• Carnevale S, Velásquez JN, Labbé JH, Chertcoff A, Cabrera M and Rodríguez MI. Diagnosis of Enterocytozoon bieneusi by PCR in Stool Samples Eluted from Filter Paper Disk. C. Diagn. Lab. Inmunol. 2000; 7, (3):504-506.
• Velásquez JN, Carnevale S, Bessaso H, Bramajo J, Kuo L, Fainboim H. Identificación de Enterocytozoon bieneusi en un paciente con colangitis esclerosante y SIDA. A. Ge. La. 2000; 30:47-51
• Olivares M, Thomas MC, López-Barajas A, Requena JM, García-Pérez JL, Ángel SO, Alonso C and López MC. Genomic clustering of the Trypanosoma cruzi non-long terminal L1Tc retrotransposon with defined interspersed repeated DNA elements. Electrophoresis. 2000; 14:2973-2982.
• Echeverría P, Rojas PA, Martín V, Guarnera EA, Pszenny V and Ángel SO. Characterization of an interspersed Toxoplasma gondii DNA repeat with potential uses for PCR diagnosis and PCR-RFLP analysis. FEMS Microbiology Letters. 2000; 184:23-27.
• SequeiraA, MolinaV, Monfellano M, Bolpe J, Guarnera E. Genetic diversity among isolates of Trichinella spiralis from the Province of Buenos Aires, Argentina. Journal of Helminthology. 2000; 74:277-282.
• Ribicich M, Rosa A, Molina V, Blangiardi G, Basso N, Franco A. Comparación etre la digestión artificial y la Triquinoscopía para la detección de Trichinella spiralis en carne porcina. In Vet; 2000 2:81-85.
• Radman N, Guardis M, Schamun A, Testi A, Archelli S, Fonrouge R, Santillán G. Toxocariosis neurológica: descripción de un caso clínico. Revista Chilena de Neuropsiquiatría. 2000; (3)
• Velásquez JN, Oelemann W, Carnevale S, Bessaso H, Etchart C, Cabrera MG, Pinto ME, Labbé JH, Kuo LH, Peralta JM. Tripanosoma cruzi en SIDA: Localización gastrointestinal y mecanismos alternativos de transmisión. Revista del Hospital Nacional Baldomero Sommer. 2000; 3:7-18.
• Ribicich M, Gamble RG, Santillán G, Miguez M, Molina V, Guarnera E, Basso N, Franco A. Evaluation of ELISA test for diagnosis of porcine Trichienllosis. The Pig Journal. 2000; (46).
• Echeverría P, Dran G, Pereda G, Rico AI, Requena JM, Alonso C, Guarnera E and Angel SO. Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination. Immun.letters. 2001; 76:107-110.
• Búa J, Aslun L, Pereyra N, García GA, Bontempi EJ, Ruiz AM. Characterisation of a cyclophilin isoform in Trypanosoma cruzi. FEMS Microbiology Letters. 2001; 200 (1): 43-47.
• Laucella SA, Riarte A, Prado N, Zapata J, Segura EL. Alpha 4 Integrins and Sialyl Lewis x Modulation in Chronic Chagas Disease; Further Evidence of Persistent Immune Activation. Scand. J. of Immunology.2001; 53 (5): 514-519.
• Chuit R, Gürtler RE, Mac Dougall L, Segura EL, Singer B, Chagas Disease- Risk assessment by an environmental approach in northern Argentina. Revista de Patologia Tropical. 2001; 30 (2): 193-207.
• Antúnez MI, Cardoni RL. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol Lett. 2001; 79(3): 189-196.
• Duschak VG, Riarte A, Segura EL, Laucella SA. Humoral Immune Response to Cruzipain and Cardiac Dysfunction in Chronic Chagas Disease. Immunol. Lett. 2001; 78: 135-142.
• Segura EL: Diagnostico de la enfermedad de Chagas. En D Hayes, MC Tentory y EL Segura, Eds “La arritmia cardíaca de orígen chagásico”, 2001.
• Segura, EL. A National Strategy for Emerging Infectious Diseases: The Argentine Case of 1999 en Emerging Infectious Disease from the Global to the Local Perspective, JR Davis and J. Lederberg, IOM, NAS. 2001.
• Carnevale S; Rodriguez MI, Santillán G, Labbé JH, Cabrera MG, Bellegarde EJ, Velázquez J, Trgovcic JE, Guarnera EA. Inmunodiagnosis of human fasciolasis by enzyme-linked inmunosorbent assay (ELISA) and Micro-ELISA. Clin Diagn. Lab. Inmunol. 2001; 8:174-177.
• Velázquez JN, Carnevale S, Monano M, Kuo LH, Caballero A, Chertcoff A, Ibáñez C, Bozzini JP. Isosporiosis and unizoite tissue cysts in patients with Acquired Inmunodeficiency Syndrome. Human Parasitology. 2001; 32:500-505.
• Carnevale S, Rodríguez MI, Guarnera EA, Carmona C, Tanos T, Ángel SO. Inmunodiagnosis of fasciolosis using recombinant pro cathepsin L cystein proteinase. Diagnostic Microbiology and Infections Diseases. 2001; 41:43-49.
• Guida MC, Esteva MI, Martino V, Pereira CA, Alonso GD, Torres HN, Flawiá MM d Paveto MC. Characterization of natural compouns with trypanocidal effect. BIOCELL. 2001; 25 (Supl. II).
• Rosenzvit MC, Canova SG, Kamenetzky L, Guarneera EA. Echinococcus granulosus: intraspecific genetic variation assessed by a DNA repetitive element. Parasitology. 2001; 381-388.
• Canova SG, Guarnera EA, Rosenzvit MC, Kamenetzky L. Echinococcus granulosus: DNA extraction from germinal layers allows strain determination in fertile and nonfertile hydatid cyst. Experimental Parasitology. 2001; 95:122-127.
• Nigro M, Martín V, Kaufer F, Carral L, Ángel SO, Pszenny V. High level expression of the Toxoplasma gondii-recombinant Rop2 protein in Escherichia coli as a soluble form for optimal use in diagnosis. Molecular Biotechnology. 2001; 18:269-273.
• Arnaiz MR, Fichera L, Postan M. Cardiac myocyte hypertrophy and proliferating cell nuclear antigen expression in wistar rats infected with Trypanosoma cruzi. J. Parasitol. 2002; 88 (5): 919- 925.
• Esteva MI, Ruiz AM, Stoka AM. Trypanosoma cruzi: methoprene is a potent agent to sterilize blood infected with trypomastigotes. Experimental Parasitology. 2002; 100: 248-251.
• Pzsenny V, Ledesma BE, Matrajt M, Duschak VG, Bontempi E, Dubremetz JFand Angel S. Subcellular localization and post-secretory targeting of TgPI, a serine proteinase inhibitor from Toxoplasma gondii Mol. and Biochem. Parasitol. 2002; 121 (2): 283-286.
• Sosa-Estani S, Martinez VP, Gonzalez Della Valle M, Edelstein A, Miguel S, Padula PJ, Cacase ML, Segura EL. Hantavirus in human and rodent population in an endemic area for hantavirus pulmonary syndrome in Argentina. Medicina (B Aires). 2002; 62 (1): 1-8.
• Segura E.L, Sosa Estani S, Esquivel ML, Salomón, OD, Gómez AO, De Rissio AM, Carlomagno MA, Riarte A, Sínagra A, Luna CA, Lanssetti, JC. Control de la Transmisión de T. cruzi en Argentina, En “Actualizaciones en Artropodología Sanitaria argentina”, compilador OD Salomón, Serie Enfermedades Transmisibles, Publicaciones Monográficas 2, Fundación Mundo Sano, 2002.
• Segura E. L. Situación del Control de la enfermedad de Chagas en Argentina, 1909-2001 (Caapitulo2), en AC Silveira ED.“Historia del Control de la Transmisión de T. cruzi en el Cono Sur de América”, Organización Panamericana de la Salud. 2002.
• Joensen L, Borda E, Trudy Kohout, Perry S, García G, Sterin-BordaL. Trypanosoma cruzi antigen that interacts with the b1-adrenergic receptor and modifies myocardial contractile activity. Mol. Biochem. Parasitol. 2003; 127: 169-177.
• García GA, Joensen GL, Bua J, Ainciart N, Perry S and Ruiz AM. Trypanosoma cruzi: Molecular identification and characterization of new members of the Tc13 family. Description of the interaction between the Tc13 antigen from Tulahuén strain and the second extracellular loop of the b1-adrenergic receptor. Exp. Parasitol. 2003; 103: 112-119.
• Minning TA, Bua J, García GA,. McGraw RA and Tarleton RL Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi. Mol. Biochem. Parasitol. 2003; 131 (1): 55-64.
• Barboza M, Duschak VG, Cazzulo JJ, De Lederkremer RM.Presence of sialic acid in N-linked oligosaccharide chains and O-linked N-acetylglucosamine in cruzipain, the major cysteine proteinase of Trypanosoma cruzi.Mol. Biochem Parasitol.2003; Vol 127 (1): 69-72.
• Duschak VG, Barboza M. and Couto AS. Trypanosoma cruzi: partial characterization of minor cruzipain isoforms non-adsorbed to Concanavalin A-Sepharose. Exp Parasitol. 2003; Vol 104 (3-4): 122-30.
• Gurtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis. 2003; 9(1): 29-32.
• Garcia BA, Manfredi C, Fichera L, Segura EL. Short report: variation in mitochondrial 12S and 16S ribosomal DNA sequences in natural populations of Triatoma infestans (Hemiptera: Reduviidae). Am J Trop Med Hyg. 2003; 68 (6): 692-4.
• Sterim-Borda L, Giordanengo L, Joensen L, Gea S. Cruzipain induces autoantibodies against cardiac muscarinic acethylcholine receptors. Funtional and pathological implications. Europ Jour of Immunology. 2003; 33(9): 2459-2468.
• Segura EL. Mitos y realidades de la utilización de sangre segura para las transfusiones (Enfermedad de Chagas), Gac Méd Méx. 2003 MG; Vol.139, Supl. No. 3, 75-9.
• Alaniz L, García M, Cabrera P, Arnaiz M, Cavaliere V, Blanco G, Alvarez E, Hajos S. Modulation of matrix metalloproteinase-9 activity by hyaluronan is depend on NF-kB activity in lymphoma cells lines with dessimilar invasive behavior. Biochem Biophys Res Commun. 2004; 324(2): 736-743.
• Antúnez MI y Cardoni RL. Trypanosoma cruzi: the expantion of NK, T and NKT cells in the experimental infections. Exp Parasitol. 2004; 106: 85-94.
• Bruno S, Duschak VG, Ledesma B, Ferella M, Björn Andersson, Guarnera AG. and Angel SO. Identification and characterization of serine proteinase inhibitors from Neospora caninum. Mol Biochem Parasitol. 2004; 136(1): 101-7.
• Búa J, Ruiz A.M., Potenza M and Fichera L. In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi. Bioorg Med Chem Lett. 2004; 14(18): 4633-7.
• Cardoni RL,García MM, De Rissio AM. Proinflammatory and anti-inflammatory cytokines in pregnant women chronically infected with Trypanosoma cruzi. Acta Trop. 2004; 90(1): 65-72.
• Cardoni RL y Antúnez MI. Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators Inflamm. 2004; 13(4): 235-40.
• Cardoni RL y Antúnez MI. Outcome of Trypanosoma cruzi infection in pregnant BALB/c mice. Ann Trop Med Parasitol. 2004; 98(8): 883-7.
• Ferraris JR, Duca P, Prigoshin N, Tambutti ML, Boldrini G, Cardoni RL and D`Agostino D. Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses.Pediatr Transplant. 2004; 8(5): 454-9.
• Ferraris JR, Tambutti ML, Cardoni R. and Prigoshin N. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses.Transplantation. 2004; 77(4): 532-7.
• García AB, Zheng L, Pérez de Rosas AR, and Segura EL, Isolation and characterization of polymorphic microsatellite loci in the chagas' disease vector Triatoma infestans (Hemiptera: Reduviidae). Molecular Ecology Notes. 2004; Vol. 4 Issue 4: 568.
• Sosa Estani S, Armenti A, Araujo G, Viotti R, Lococo B, Ruiz Vera B, Vigliano C, De Rissio AM, Segura EL. Tratamiento de la enfermedad de Chagas con Benznidazol y ácido tióctico. Medicina (Buenos Aires) 2004; 64:1-6.
• Fichera LE, Albareda MC, Laucella S, Postan M. Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced NO release. Infection and Immunity. 2004; Vol. 72: 359-363.
• Ghedin E, Bringaud F, Peterson J, Myler P, Berriman M, Ivenz A, Andersson B, Bontempi EJ, Eisen J, Angiuoli S, Wanless D, Von Arx A, Murphy L, Lennard N, Salzberg S, Adams. MD, White O, Hall N, Stuart K, Fraser CM, El-Sayed NMA. Gene synteny and evolution of genome architecture in trypanosomatids. Molecular and Biochemical Parasitology. 2004; 134: 183-191.
• Laucella SA, Postan M, Martín D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis. 2004; 189(5): 909-18.
• Paveto C, Guida MC, Esteva MI, Martino V, Coussio J, Flawiá MM and Torres HN. Anti- Trypanosoma cruzi activity of green tea (Camellia sinensis) cathechins. Antimicrob. Agent Chemother. 2004; 48(1): 69-74.
• Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, Ruiz Vera B, Armenti H. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiommyopathy without heart failure. Heart. 2004; 90: 655-660.
• Gürtler RE, Canale DM, Spillmann C, Stariolo R, Salomon OD, Blanco S, Segura EL, Effectiveness of residual spraying of peridomestic ecotopes with deltamethrin and permethrin on Triatoma infestans in rural western Argentina: a district-wide randomized trial. Bull World Health Organ. 2004; 82(3): 196-205.
• Ruiz AM, Bua J y Garcia GA. La Enfermedad de Chagas. En Parasitosis Regionales, Ed Costamagna SR. Editorial de la Universidad Nacional del Sur, Bahia Blaca, Argentina. 2004; Pag: 23-71
• Esteva MI, Maidana C, Sinagra A, Luna C, Ruiz AM and Stoka AM. Effect of a juvenile hormone analogue on Leishmania amazonensis and Leishmania braziliensis. Exp Parasitol. 2005; 110(2):162-164.
• Cardoni RL, Prigoshin N, Tambutti ML, Ferraris JR. Citoquinas reguladoras de la respuesta al trasplante renal alogénico. Medicina (Buenos Aires). 2005; 65: 54-62.
• Gürtler R, Cecere MC, Lauricella M, Petersen, Chuit R, Segura El and Cohen J. Incidence of Trypanosoma cruzi ifection among children following domestic reinfestation after insecticide spraying in rural northwestern Argentina. The American Society of Tropical Medicine and Hygiene. 2005; 73(1): 95-103.
• Lauricella MA, Stariolo RL, Riarte AR, Segura EL, Gürtler RE. Distributión and Pathogenicity of Trypanosoma cruzi isolated from peridomestic populations of triatoma infestans and triatoma guasayana from rural western Argentina. Mem. Inst.Oswaldo Cruz. 2005; Vol. 100: 123-129.
• Altclas J, Sinagra A, Dictar M, Luna C, Verón M, De Rissio AM, García MM, Salgueira C. and Riarte A. Chagas’ disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplantation. 2005; 36: 123-129.
• Barcán L, Luna C, Clara L, Sinagra A, Valledor A, De Rissio AM, Gadonoa A, García MMC, de Santi Bañez E, Riarte A. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas’ Disease. Liver Transplantation. 2005; Vol 11(9): 1112-1116.
• Esteva MI, Kettler K, Maidana C, Fichera L, Ruiz AM, Bontempi EJ, Andersson B, Dahse HM, Haebel P, Ortmann R, Klebe G, Schlitzer M. Benzophenone-Based Farnesyltransferase Inhibitors with High Activity against Trypanosoma cruzi. JMed Chem. 2005; 48(23):7186-7191.
• Segura EL, Escobar-Mesa A; Grupo de Estudio sobre la Enfermedad de Chagas. Epidemiology of Chagas disease in the state of Veracruz Salud Publica Mex. 2005; 47 (3): 201-8.
• Irañeta SG, Seoane MA, Apicella C, Alonso A and Duschak VG. Antigenicity and immunocross-reactivity of orange tree pollen and orange fruit allergenic extracts. Allergy and Immunology. 2005; 137(4): 265-72.
• Duschak VG, Barboza M, Garcia GA, Lammel EM, Couto AS, Isola EL. Novel cysteine proteinase in Trypanosoma cruzi metacyclogenesis. Parasitology. 2005; 21: 1-11.
• Barboza M, Duschak VG, Fukuyama Yuko, Hiroshi Nonami, R. Erra-Balsells, Cazzulo JJ and Couto A. Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides. FEBS J. 2005; 272(15): 3803-15.
• Puyó AM, Scaglione J, Cavallero S, Postan M. & Fernandez BE. Natriuretic peptides as prognostic and diagnostic markers in Chagas' disease. Regul Pept. 2005; 128(3): 203-10.
• El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G, Westenberger SJ, Caler E, Cerqueira GC, Branche C, Haas B, Anupama A, Arner E, Aslund L, Attipoe P, Bontempi E, et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science. 2005; 309(5733): 409-415.
• Garcia GA, Arnaiz MR, Laucella SA, Esteva MI, Ainciart N, Riarte A, Garavaglia PA, Fichera LE, Ruiz AM. Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi. Parasitology. 2006; 132(6): 855-866.
• Potenza M, Galat A, Minning TA, Ruiz AM, Duran R, Tarleton RL, Marín M, Fichera L y Búa J. Análisis of the Tripanosoma cruzi cyclophilin gene family and identification of cyclosporin A binding proteins. Parasitology. 2006; 132: 867-882.
• Viotti R, MD; Vigliano C, MD; Lococo B, MD; Bertocchi G, MD; Petti M, MD; Alvarez MG, MD; Postan M, MD, PhD; and Armenti A, MD. Long-Term carric outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Annals of Internal Medicine. 2006; 144 (10): 724-774.
• Cianciulli TF, Lax JA, Sacheri MC, Papantoniou A, Morita LA, Prado NG, Dorelle AN, Riarte AR, Prezioso HA. Early detection of left ventricular diastolic dysfunction in Chagas´disease. Cardiovascular Ultrasound. 2006; 4-18
• Salomón D, Sosa –Estani S, Ramos K, Orellano PW, Sangüesa G, Fernández G, Sinagra A, Rapasciolli G. Tegumentary leishmaniasis outbreak in Bella Vista city, Corrientes, Argentina during 2003. Mem Inst Oswaldo Cruz. 2006; Vol 101(7):767-774

2007 – 2008

• Guida Maria C, Esteva Monica I., Camino Alejandra, Flawia Mirta M., Torres Hector N, Paveto Cristina. (2007). Trypanosoma cruzi:In vitro and in vivo antiproliferative effects of epigallacatechin gallate (EGCg). Experimental Parasitology117:188-194
• Garcia G.A.; Arnaiz M.R., Esteva M.I., Laucella S.A., Garavaglia P.A., Ibarra S.E., Ruiz A.M..(2007). Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.Parasitology 135: 347-357
• Carraro Roberto, Bua Jacqueline, Ruiz Andres, Paulino .(2007). Modelling and study of cyclosporin A and related compounds in complexes with a Trypanosoma cruzi cyclophilin. Journal of Molecular Graphics and Modelling 26 : 48–61
• Duschak Vilma G,. Couto Alicia S.(2007). An Insight on Targets and Patented Drugs for Chemotherapy of ChagasDisease. Recent Patents on Anti-Infective Drug Discovery, 2007, 2: 000-000.
• Galindo Mario, Sabaj Valeria, Espinoza Ingrid, Toro Gabriela Cecilia, Bua Jaqueline, Grenet Jose, Lopez-Sol?s Remigio, Ruiz Andres Mariano, Galanti Norbel(2007). Chromosomal size conservation through the cell cycle supports karyotype stability in Trypanosoma cruzi. FEBS Letters 581 :2022–2026
• Gurtler R. E,. Cereme M. C,. Lauricella M. A,. Cardinal M.V, Kitron U , Cohen J. E.(2007). Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology , 134: 69–82.
• Ochaya Stephen, Respuela Patricia, Simonsson Maria, Saraswathi Abhiman,
Branche Carole , Lee Jennifer , Bua Jacqueline , Nilsson Daniel ,Aslund Lena, Bontempi Esteban J., Andersson Bjorn (2007) Characterization of a Trypanosoma cruzi acetyltransferase: cellular location, activity and structure . Molecular Biochemical Parasitology 152 : 123–131
• Adelina Riarte, N. Prado, C.Luna, E.Velázquez, AM De Rissio, ME. Echeverry, Y. Hernández, AM. Ruiz, M.Esteva, A. Sinagra. Enfermedad de Chagas. Una Actualización Preliminar. www.fac.org.ar/qcvc/llave/c131e/ruiaza.pdf. Federación Argentina de Cardiología. 5to. Congreso Internacional de Cardiologia. 5to.Congreso Virtual de Cardiología – QCVC. 2007
• Ruiz Andrés Mariano Riarte Adelina, De Rissio Ana María, Esteva Mónica Inés, Bua Jacqueline, Lago Noemí, Paez Rubén Carrizo y Trainini Jorge Carlos.(2007). NUEVAS EVIDENCIAS EN LA ENFERMEDAD DE CHAGAS.
APORTES DEL INSTITUTO FATALA CHABEN A LA PREVENCIÓN, CONTROL Y SU TRATAMIENTO
• Sinagra, Ángel; Luna, Concepción; Abraham, David; Iannella, Maria del Carmen; Riarte, Adelina; Krolewiecki, Alejandro J. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model. Rev. Soc. Bras. Med Trop 40, Nº 6, 2007.
• JC Trainini, J Barisani, N Lago, J Bordone, J Mouras, A Ruiz, O Masoli, R Carrizo Paez, S Chada, A Christen, A Riarte. Resultados alejados del implante de células madre en la miocardiopatía chagásica. Rev Arg Cardiol 75: 257-263, 2007.
• OD Salomon, A Sinagra, MC Nevot, G Barberian, P Paulin, JO Estevez, A Riarte, J Estevez. First visceral leishmaniasis focus in Argentina. Mem Inst Osw Cruz 103: 109-11, 2008
• J Altclass, L Barcan, C Nagel, R Lattes, A Riarte.Organ Transplantation and Chagas disease. JAMA, 299 (10) 1134-35, 2008.

2009 – 2010

Albareda MC, Olivera GC, Laucella SA, Alvarez MG, Fernandez ER, Lococo B, Viotti R, Tarleton RL, Postan M. Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol. 2009 Sep 15;183(6):4103- 8.
• Cutrullis RA, Postan M, Petray PB, Corral RS. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Pathobiology. 2009;76(4):170-80. Epub 2009 Jun 29.
• De Rissio AM, Scollo K, Cardoni RL. [Maternal-fetal transmission of Trypanosoma cruzi in Argentina] Medicina (B Aires). 2009;69(5):529-35.
• Duschak VG, Couto AS Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-202.
• Ibáñez CI, Bozzini JP, Mariano MI. Triatoma infestans (Klug1834)’s EMBRIOLOGY [II] GONADOGENESIS. Acta Microscopica Vol. 18, No. 1, 2009, pp. 1–18. (Venezuela)
• Laucella SA., Perez Mazliah D, Bertocchi G, Alvarez MG., Cooley G, Viotti R, Albareda MC, Lococo B, Postan M, Armenti A, Tarleton RL. Changes in Trypanosoma cruzi –Specic Immune Responses after Treatment: Surrogate Markers of Treatment Eficacy. Clin Infect Dis. 2009 Dec 1;49(11):1675-84.
• Segura EL, Torres AG, Fusco O, García BA. Mitochondrial 16S DNA variation in populations of Triatoma infestans from Argentina. Med Vet Entomol. 2009 Mar;23(1):34-40.
• Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection. Parasitology. 2009 May;136(6):627-39. Epub 2009 Apr 14
• Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7.
• Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):167-80.
• Tekiel V, Alba-Soto CD, González Cappa SM, Postan M, Sánchez DO. Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Epub 2009 Jan 20 de Rissio AM, Scollo K, Cardoni RL. Maternal-fetal transmission of Trypanosoma cruzi in Argentina. Medicina (B Aires).2009;69(5):529-35
• Albareda MC, Olivera GC, Laucella SA, Alvarez MG, Fernandez ER, Lococo B, Viotti R, Tarleton RL, Postan M. Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol. 2009 Sep 15;183(6):4103-8.
• Cutrullis RA, Postan M, Petray PB, Corral RS. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.Pathobiology. 2009;76(4):170-80. Epub 2009 Jun 29.
• De Rissio AM, Scollo K, Cardoni RL. [Maternal-fetal transmission of Trypanosoma cruzi in Argentina] Medicina (B Aires). 2009;69(5):529-35.
• Duschak VG, Couto AS Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-20
• Ibáñez CI, Bozzini JP, Mariano MI. Triatoma infestans (Klug1834)’s EMBRIOLOGY [II] GONADOGENESIS. Acta Microscopica Vol. 18, No. 1, 2009, pp. 1–18. (Venezuela)
• Laucella SA., Perez Mazliah D, Bertocchi G, Alvarez MG., Cooley G, Viotti R, Albareda MC, Lococo B, Postan M, Armenti A, Tarleton RL. Changes in Trypanosoma cruzi –Specic Immune Responses after Treatment: Surrogate Markers of Treatment Eficacy. Clin Infect Dis. 2009 Dec 1;49(11):1675-84.
• Segura EL, Torres AG, Fusco O, García BA. Mitochondrial 16S DNA variation in populations of Triatoma infestans from Argentina. Med Vet Entomol. 2009 Mar;23(1):34-40.
• Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM.Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection. Parasitology. 2009 May;136(6):627-39. Epub 2009 Apr 14
• Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7.
• Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):167-80.
• Tekiel V, Alba-Soto CD, González Cappa SM, Postan M, Sánchez DO. Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Epub 2009 J
• De Rissio Ana María; Riarte Adelina Rosa; García Miriam Martín; Esteva Mónica Inés; Quaglino Marta; Ruiz Andrés Mariano. Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am. J. Trop. Med. Hyg., 82(5), 2010, pp. 838–845.
• Albareda María Cecilia; Olivera Gabriela Carina; De Rissio Ana María; Postan Miriam
Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.
Am. J. Trop. Med. Hyg., 82(5), 2010, pp. 861–864.
• Andrzej Galat, Jacqueline Búa. Molecular aspects of cyclophilins mediating therapeutic actions of their ligands. Cell. Mol. Life Sci. (2010) 67:3467–3488.
Vilma G. Duschak and Alicia S. Couto. Targets and Patented Drugs for Chemotherapy of Chagas Disease. Frontiers in Anti-Infective Drug Discovery, 2010, (1), 323-408 323.
• Patricia A. Garavagliaa, Joaquín J.B. Cannatab,c, Andrés M. Ruiza, Dante Maugeric, Rosario Durand, Mónica Galleanoe, Gabriela A. García. Identification, cloning and characterization of an aldo-keto reductase from Trypanosoma cruzi with quinone oxido-reductase activity. Molecular & Biochemical Parasitology 173 (2010) 132–141.
• Noelia L. Grosso, Jacqueline Búa, Alina E. Perrone, Mariela N. Gonzalez, Patricia L. Bustos, Miriam Postan, Laura E. Fichera. Trypanosoma cruzi: Biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. Exp. Parasitotol. 126 (2010) 239–244.
• Olivera GC, Albareda MC, Alvarez MG, De Rissio AM, Fichera LE, Cooley G, Yachelini P, Hrellac HA, Riboldi H, Laucella SA, Tarleton RL, Postan M. Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina.. Microbes and Infection 12 (2010) 359-363.
• Mallimaci MC, Sosa-Estani S, Russomando G, Sanchez Z, Sijvarger C, Alvarez IM, Barrionuevo L, Lopez C, Segura EL.Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.
Am J Trop Med Hyg. 2010.82(1):55-9.
• Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL.Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J Control Release. 2010;147(3):368-76.
• Cazorla SI, Frank FM, Becker PD, Arnaiz M, Mirkin GA, Corral RS, Guzmán CA, Malchiodi EL.Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection. J Infect Dis. 2010;202(1):136-44.
• Chagas disease and Solid Organ Transplantation. The Chagas’ Disease Argentine Collaborative Transplant Consortium and Domingo Casadei. Transplantation Proceedings, 42, 3354–3359, 2010.
• Zocratto KB, Osimani ML, Peralta LM, Latorre L, Muzzio E, Segura M, Chiparelli H, Proietti FA, Rey J, Vazquez E, Cuchi P, Sosa-Estani S, Rossi D, Weissenbacher M, Caiaffa WT Sexual behavior and HBV infection among noninjecting cocaine users (NICUs). Subst Use Misuse. 2010 Oct; 45(12):2026-44

2011 – 2012

• Acosta DM, Soprano LL, Ferrero M, Landoni M, Esteva MI, Couto AS, Duschak VG. A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin. Parasite Immunol. 2011 Jul; 33(7): 363-70.
• Cutrullis RA, Moscatelli GF, Moroni S, Volta BJ, Cardoni RL, Altcheh JM, Corral RS, Freilij HL, Petray PB. Benznidazole therapy modulates interferon-? and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children. PLoS One. 2011;6 (10):e27133..
• Cutrullis RA, Poklépovich TJ, Postan M, Freilij HL, Petray PB. Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection. Int Immunopharmacol.2011. 11(8):1024-31
• Duschak Vilma G. A decade of targets and patented drugs for chemotherapy of Chagas Disease. Recent Patents in Anti-infective drug discovery, 2011; 6(3):216-59.
• Pérez de Rosas AR, Segura EL, García BA. Molecular phylogeography of the Chagas’ disease vector Triatoma infestans in Argentina Heredity (Edinb). 2011. 107(1):71-9.
• Viotti R, Vigliano C, Alvarez MG, Lococo B, Petti M, Bertocchi G, Armenti A, De Rissio AM, Cooley G, Tarleton R, Laucella S. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis. 2011. 5(9):e1314.
• Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, Cura C, Auter F, Veron V, Qvarnstrom Y, Deborggraeve S,Hijar G, Zulantay I, Lucero RH, Velazquez E, Tellez T, Sanchez Leon Z, Galvão L, Nolder D, Monje Rumi M, Levi JE, Ramirez JD,Zorrilla P, Flores M, Jercic MI, Crisante G, Añez N, De Castro AM, Gonzalez CI, Acosta Viana K, Yachelini P, Torrico F, Robello C,Diosque P, Triana Chavez O, Aznar C, Russomando G, Büscher P, Assal A, Guhl F, Sosa Estani S, DaSilva A, Britto C, Luquetti A,Ladzins J. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011. 5(1):e931.
• Avila ML, Tekiel V, Moretti G, Nicosia S, Búa J, Lammel EM, Stroppa MM, Gerez de Burgos NM, Sánchez DO. Gene discovery in Triatoma infestans. Parasit Vectors. 2011. 4:39.
• Schijman AG, Bisio M, Orellana L, Sued M, Duffy T. International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients., et al. (2011) PLoS Negl Trop Dis 5(1): e931.
• Caiaffa WT, Zocratto KF, Osimani ML, Martínez PL, Radulich G, Latorre L, Muzzio E, Segura M, Chiparelli H, Russi J, Rey J, Vazquez E, Cuchi P, Sosa-Estani S, Rossi D, Weissenbacher M. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge. Addiction. 2011 Jan;106(1):143-51.
• Gamboa-León R, Gonzalez-Ramirez C, Padilla-Raygoza N, Sosa-Estani S, Caamal-Kantun A, Buekens P, Dumonteil E. Do Commercial Serologic Tests for Trypanosoma cruzi Infection Detect Mexican Strains in Women and Newborns?. J Parasitol. 2011 Apr;97(2):338-43.
• Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti A, Freilij H, Albajar-Viñas P. Congenital transmission of Trypanosoma cruzi infection (congenital Chagas disease). Recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. Plos Neglected Tropical Diseases. Accepted. June 2011.
• Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in non endemic areas. María-Jesús Pinazo, Blanca Miranda, Camino Rodríguez-Villar, Javier Altclas, Mercè Brunet Serra, Elías Cañas García-Otero, Eros Antonio de Almeida, Manuel de la Mata García, Joaquim Gascon, Magdalena García Rodríguez, Nicolás Manito, Asunción Moreno Camacho, Federico Oppenheimerl, Sabino Puente Puente, Adelina Riarte, Joaquín Salas Coronas, Miguel Salavert Lletí, Guillermo F. Sanz, Faustino Torrico, Diego Torrús Tendero, Piedad Ussetti, Maria Aparecida Shikanai-Yasuda. Transplantation Review. 2011. doi:10.1016/j.trre.2010.12.002
• Acosta DM, Soprano LL, Ferrero MR, Esteva MI, Riarte A, Couto AS, Duschak VG. Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates.Parasite Immunol. 2012 Nov; 34(11):499-510.
• Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One. 2012;7(5):e35966. doi: 10.1371/journal.pone.0035966. Epub 2012 May 4.
• Bua J, Volta BJ, Velazquez EB, Ruiz AM, Rissio AM, Cardoni RL. Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification. Trans R Soc Trop Med Hyg. 2012 Oct;106(10):623-8. doi: 10.1016/j.trstmh.2012.03.015. Epub 2012 Jul 24.
• Couto AS, Soprano LL, Landoni M, Pourcelot M, Acosta DM, Bultel L, Parente J, Ferrero MR, Barbier M, Dussouy C, Esteva MI, Kovensky J, Duschak VG. An anionic synthetic sugar containing 6-SO3 -NAcGlc mimics the sulfated cruzipain epitope that plays a central role in immune recognition. FEBS J. 2012 Oct;279(19):3665-79. doi: 10.1111/j.1742-4658.2012.08728.x. Epub 2012 Sep 4.
• Cura CI, Lucero RH, Bisio M, Oshiro E, Formichelli LB, Burgos JM, Lejona S, Brusés BL, Hernández DO, Severini GV, Velazquez E, Duffy T, Anchart E, Lattes R, Altcheh J, Freilij H, Diez M, Nagel C, Vigliano C, Favaloro L, Favaloro RR, Merino DE, Sosa-Estani S, Schijman AG. Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina. Parasitology. 2012 Apr;139(4):516-21.
• Gulin JE, Eagleson MA, Postan M, Cutrullis RA, Freilij H, Bournissen FG, Petray PB, Altcheh J. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection. J Antimicrob Chemother. 2012 Dec 4. [Epub ahead of print]
• Lai DH, Bontempi EJ, Lukeš Trypanosoma brucei solanesyl-diphosphate synthase localizes to the mitochondrion. J. Mol Biochem Parasitol. 2012 Jun;183(2):189-92.
• Pérez-Mazliah D, Albareda MC, Alvarez MG, Lococo B, Bertocchi GL, Petti M, Viotti RJ, Laucella SA. Allopurinol reduces antigen-specific and polyclonal activation of human T cells.Front Immunol. 2012;3:295. doi: 10.3389/fimmu.2012.00295. Epub 2012 Sep 21.
• Sosa-Estani S, Colantonio L, Segura EL. Therapy of Chagas disease: implications for levels of prevention. J Trop Med. 2012;2012:292138.
• Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, Petti M, Albareda MC, Armenti AH, Tarleton RL, Laucella SA, Viotti R. Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother. 2012 Nov 1. [Epub ahead of print]
• Moreira OC, Ramírez JD, Velázquez E, Melo MF, Lima-Ferreira C, Guhl F, Sosa-Estani S, Marin-Neto JA, Morillo CA, Britto C. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: A substudy from the BENEFIT trial. Acta Trop. 2013 Jan;125(1):23-31. doi: 10.1016/j.actatropica.2012.08.020. Epub 2012 Sep 12
• Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, Petti M, Albareda MC, Armenti AH, Tarleton RL, Laucella SA, Viotti R. Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother. 2012 Nov 1. [Epub ahead of print]

2013 – 2015

• Duffy T, Cura CI, Ramirez JC, Abate T, Cayo NM, Parrado R, Bello ZD, Velazquez E, Muñoz-Calderon A, Juiz NA, Basile J, Garcia L, Riarte A, Nasser JR, Ocampo SB, Yadon ZE, Torrico F, de Noya BA, Ribeiro I, Schijman AG. Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood Samples.PLoS Negl Trop Dis. 2013 Jan;7(1):e2000. doi: 10.1371/journal.pntd.0002000. Epub 2013 Jan 17
• Crocco MC, Fratnz N, Bos-Mikich A. Substrates and supplements for hESCs: a critical review. J Assist Reprod Genet. 2013 Jan 4. [Epub ahead of print]
• Cutrullis RA, Petray PB, Schapachnik E, Sánchez R, Postan M, González MN, Martín V, Corral RS. Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease. PLoS One. 2013;8(2):e57181. doi: 10.1371/journal.pone.0057181. Epub 2013 Feb 22.
• Argüello RJ, Vigliano C, Cabeza-Meckert P, Viotti R, Garelli F, Favaloro LE, Favaloro RR, Laguens R, Laucella SA. Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic chagas disease myocarditis.PLoSNegl Trop Dis. 2014 Aug 21;8(8):e2989. doi: 10.1371/journal.pntd.0002989. eCollection 2014 Aug. PMID:25144227
• Enriquez GF, Bua J, Orozco MM, Wirth S, Schijman AG, Gürtler RE, Cardinal MV. High levels of Trypanosomacruzi DNA determined by qPCR and infectiousness to Triatomainfestans support dogs and cats are major sources of parasites for domestic transmission. Infect Genet Evol. 2014 Jul;25:36-43. doi: 10.1016/j.meegid.2014.04.002. Epub 2014 Apr 13.PMID:24732410
• Dell'Arciprete A, Braunstein J, Touris C, Dinardi G, Llovet I, Sosa-Estani S. Cultural barriers to effective communication between Indigenous communities and health care providers in Northern Argentina: an anthropological contribution to Chagas disease prevention and control. Int J Equity Health. 2014 Jan 29;13:6
• Fabbro DL, Danesi E, Olivera V, Codebó MO, Denner S, Heredia C, Streiger M, Sosa-Estani S. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312.
• Fernández ER, Olivera GC, Quebrada Palacio LP, González MN, Hernandez-Vasquez Y, Sirena NM, Morán ML, Ledesma Patiño OS, Postan M. Altered Distribution of Peripheral Blood Memory B Cells in Humans Chronically Infected with Trypanosomacruzi.PLoS One. 2014 Aug 11;9(8):e104951. doi: 10.1371/journal.pone.0104951. eCollection 2014. PMID: 25111833
• Fernández Mdel P, Cecere MC, Lanati LA, Lauricella MA, Schijman AG, Gürtler RE, Cardinal MV. Geographic variation of Trypanosomacruzi Discrete Typing Units from Triatomainfestans at different spatial scales.Acta Trop. 2014 Dec;140:10-8. doi: 10.1016/j.actatropica.2014.07.014. Epub 2014 Aug 1.PMID:25090650
• Ferrero MR, Soprano LL, Acosta DM, García GA, Esteva MI, Couto AS, Duschak VG. Effects of chlorate on the sulfation process of Trypanosoma cruzi glycoconjugates. Implication of parasite sulfates in cellular invasion. Acta Trop. 2014 Sep;137:161-73. doi: 10.1016/j.actatropica.2014.05.014. Epub 2014 May 28. PMID: 24879929
• Lai DH, Poropat E, Pravia C, Landoni M, Couto AS, Pérez Rojo FG, Fuchs AG, Dubin M, Elingold I, Rodríguez JB, Ferella M, Esteva MI, Bontempi EJ, Lukes J. Solanesyl diphosphate synthase, an enzyme of the ubiquinone synthetic pathway, is required throughout the life cycle of Trypanosoma brucei. Eukaryot Cell. 2013 Dec 27. [Epub ahead of print] PMID:24376001
• Pinazo MJ, Thomas MC, Bua J, Perrone A, Schijman AG, Viotti RJ, Ramsey JM, Ribeiro I, Sosa-Estani S, López MC, Gascon J. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Rev Anti Infect Ther. 2014 Apr;12(4):479-96. doi: 10.1586/14787210.2014.899150. PMID: 24621252
• Velázquez EB, Rivero R, Rissio AM, Malagrino N, Esteva MI, Riarte AR, Ruiz AM. Predictive role of polymerase chain reaction in the early diagnosis of congenital Trypanosomacruzi infection. Acta Trop. 2014 Jun 2;137C:195-200. doi: 10.1016/j.actatropica.2014.05.016. Epub 2014 Jun 2. PMID: 24892867
• Villar JC, Perez JG, Cortes OL, Riarte A, Pepper M, Marin-Neto JA, Guyatt GH. Trypanocidal drugs forchronic asymptomatic Trypanosomacruzi infection. Cochrane Database of Systematic Reviews 2002 , Issue 1 . Art. No.: CD003463. DOI: 10.1002/14651858.CD003463 .
• Sánchez-Camargo CL, Albajar-Viñas P, Wilkins PP, Nieto J, Leiby DA, Paris L, Scollo K, Flórez C, Guzmán-Bracho C, Luquetti AO, Calvo N, Tadokoro K, Saez-Alquezar A, Palma PP, Martin M, Flevaud L. Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosomacruzi antibodies in serum banks in areas of endemicity and nonendemicity. J ClinMicrobiol. 2014 Jul;52(7):2506-12. doi: 10.1128/JCM.00144-14. Epub 2014 May 7.
• Viotti R, Alarcón de Noya B, Araujo-Jorge T, Grijalva MJ, Guhl F, López MC, Ramsey JM, Ribeiro I, Schijman AG, Sosa-Estani S, Torrico F, Gascon J; Latin American Network for Chagas Disease, NHEPACHA. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2014;58(2):635-9.
• Albareda MC, Laucella SA. Modulation of trypanosoma cruzi-specific T-cell responses after chemotherapy of chronic Chagas disease. Memorias del Instituto Oswaldo Cruz Vol. 110 Mayo 2015
• Albareda MC, Perez-Mazliah D, Natale MA, Castro-Eiro M, Alvarez MG, Viotti R, Bertocchi G, Lococo B, Tarleton RL, Laucella SA. Perturbed T Cell IL-7 Receptor Signaling in Chronic Chagas Disease.J Immunol. 2015 Apr 15;194(8):3883-9. doi: 10.4049/jimmunol.1402202. Epub 2015 Mar 13.PMID:25769928
• Benassi L, Bosio A, Dalipi R, Borgese L, Rodella N, Pasquali M, Depero LE, Bergese P, Bontempi E. Comparison between rice husk ash grown in different regions for stabilizing fly ash from a solid waste incinerator. J Environ Manage. 2015 Aug 15;159:128-34. doi: 10.1016/j.jenvman.2015.05.015. Epub 2015 Jun 7. PMID:26063517
• Benatar AF, García GA, Bua J, Cerliani JP, Postan M, Tasso LM, Scaglione J, Stupirski JC, Toscano MA, Rabinovich GA, Gómez KA. Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells. PLoS Negl Trop Dis. 2015 Oct 9;9(10):e0004148. doi: 10.1371/journal.pntd.0004148. eCollection 2015 Oct.
• Bustos Patricia, Perrone Alina, Milduberger Natalia y Bua Jacqueline. Improved Immuno-Detection of a Low-Abundance Cyclophilin Allows the Confirmation of Its Expression in a Protozoan Parasite. Revista: Immunochemistry & Immunopathology. Open Access Access 2015, 1:1 http://dx.doi.org/10.4172/icoa.1000103PMID: 26451839
• Bustos PL, Perrone AE, Milduberger N, Postan M, Bua J. Oxidative stress damage in the protozoan parasite Trypanosoma cruzi is inhibited by Cyclosporin A.Parasitology. 2015 Jul;142(8):1024-32. doi: 10.1017/S0031182015000232. Epub 2015 Mar 31 PMID: 25823521
• Ferrero MR, Heins AM, Soprano LL, Acosta DM, Esteva MI, Jacobs T, Duschak VG. Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.Med Microbiol Immunol. 2015 Jun 6. PMID: 26047932
• Juiz NA, Cayo NM, Burgos M, Salvo ME, Nasser JR, Búa J, Longhi SA, Schijman AG. Human Polymorphisms in Placental Expression Genes and Their Association to Susceptibility to Congenital Infection by Trypanosoma cruzi. J Infect Dis. 2015 Nov 23. pii: jiv561. [Epub ahead of print] PMID: 26597259
• Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S; BENEFIT Investigators. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med. 2015 Oct;373(14):1295-306. doi: 10.1056/NEJMoa1507574. Epub 2015 Sep 1. PMID: 26323937
• Olivera GC, Postan M, González MN.Effects of artesunate against Trypanosma cruzi. Exp Parasitol. 2015 May 27;156:26-31. doi: 10.1016/j.exppara.2015.05.014. PMID: 26024969
• Volta BJ, Russomando G, Bustos PL, Scollo K, De Rissio AM, Sánchez Z, Cardoni RL, Bua J. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples. Acta Trop. 2015 Apr 3;147:31-37. doi: 10.1016/j.actatropica.2015.03.026. PMID: 25847262
• Rêgo JV, Duarte AP, Liarte DB, de Carvalho Sousa F, Barreto HM, Bua J, Romanha AJ, Rádis-Baptista G, Murta SM. Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole.Exp Parasitol. 2015 Jan;148:73-80. doi: 10.1016/j.exppara.2014.11.007. Epub 2014 Nov 20.
• Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients. Juan Carlos Ramírez, Carolina Inés Cura, Otacilio da Cruz Moreira,y Eliane Lages-Silva, Natalia Juiz, Elsa Velázquez, Juan David Ramírez, Anahí Alberti, Paula Pavia, María Delmans Flores-Chávez,yy Arturo Muñoz-Calderón, Deyanira Pérez-Morales, José Santalla, Paulo Marcos da Matta Guedes, Julie Peneau, Paula Marcet, Carlos Padilla, David Cruz-Robles, Edward Valencia, Gladys Elena Crisante, Gonzalo Greif, Inés Zulantay, Jaime Alfredo Costales, Miriam Alvarez-Martínez, Norma Edith Martínez, Rodrigo Villarroel, Sandro Villarroel, Zunilda Sánchez, Margarita Bisio, Rudy Parrado, Lúcia Maria da Cunha Galvão, Antonia Cláudia Jácome da Câmara, Bertha Espinoza, Belkisyole Alarcón de Noya, Concepción Puerta, Adelina Riarte, Patricio Diosque, Sergio Sosa-Estani, Felipe Guhl, Isabela Ribeiro, Christine Aznar, Constança Britto, Zaida Estela Yadón, and Alejandro G. Schijman. DOI: http://dx.doi.org/10.1016/j.jmoldx.2015.04.010
• New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients. Álvarez MG, Hernández Y, Bertocchi G, Fernández M, Lococo B, Ramírez JC, Cura C, Albizu CL, Schijman A, Abril M, Sosa-Estani S, Viotti R. Antimicrob Agents Chemother. 2015 Nov 23;60(2):833-7. doi: 10.1128/AAC.00745-15.
• Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S. PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015.
• Text message interventions for follow up of infants born to mothers positive for Chagas disease in Tucumán, Argentina: a feasibility study. Cormick G, Ciganda A, Cafferata ML, Ripple MJ, Sosa-Estani S, Buekens P, Belizán JM, Althabe F. BMC Res Notes. 2015 Sep 29;8:508. doi: 10.1186/s13104-015-1498-9.
• [Guiding the etiological treatment of Chagas disease]. Sosa Estani S, Altcheh J, Riarte A, Freilij H, Fernandez M, Lloveras S, Pereiro A, Castellano LG, Salvatella R, Nicholls RS; Grupo de Trabajo. Medicina (B Aires). 2015;75(4):270-1.
• Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment. Porrás AI, Yadon ZE, Altcheh J, Britto C, Chaves GC, Flevaud L, Martins-Filho OA, Ribeiro I, Schijman AG, Shikanai-Yasuda MA, Sosa-Estani S, Stobbaerts E, Zicker F. PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun.
• Integrated control of Chagas disease for its elimination as public health problem--a review. Sosa-Estani S, Segura EL. Mem Inst Oswaldo Cruz. 2015 May;110(3):289-98. doi: 10.1590/0074-02760140408.
• Congenital Chagas disease: an update. Carlier Y, Sosa-Estani S, Luquetti AO, Buekens P. Mem Inst Oswaldo Cruz. 2015 May;110(3):363-8. doi: 10.1590/0074-02760140405. Epub 2015 Mar 6.
• Ramírez JC, Cura CI, da Cruz Moreira O, Lages-Silva E, Juiz N, Velázquez E, Ramírez JD, Alberti A, Pavia P, Flores-Chávez MD, Muñoz-Calderón A, Pérez-Morales D, Santalla J, Marcos da Matta Guedes P, Peneau J, Marcet P, Padilla C, Cruz-Robles D, Valencia E, Crisante GE, Greif G, Zulantay I, Costales JA, Alvarez-Martínez M, Martínez NE, Villarroel R, Villarroel S, Sánchez Z, Bisio M, Parrado R, Maria da Cunha Galvão L, Jácome da Câmara AC, Espinoza B, Alarcón de Noya B, Puerta C, Riarte A, Diosque P, Sosa-Estani S, Guhl F, Ribeiro I, Aznar C, Britto C, Yadón ZE, Schijman AG. Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients. J Mol Diagn. 2015 Sep;17(5):605-15. doi: 10.1016/j.jmoldx.2015.04.010. PMID: 6320872
• Volta BJ, Russomando G, Bustos PL, Scollo K, De Rissio AM, Sánchez Z, Cardoni RL, Bua J. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples. Acta Trop. 2015 Apr 3;147:31-37. doi: 10.1016/j.actatropica.2015.03.026. PMID: 2584726

2016 – 2017

• Alvarez MG, Bertocchi GL, Cooley G, Albareda MC, Viotti R, Perez-Mazliah DE, Lococo B, Castro Eiro M, Laucella SA, Tarleton RL.Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses. PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004657. doi: 10.1371/journal.pntd.0004657. PMID: 27128444
• Ayala MA, Casasco A, González M, Postan M, Corral RS, Petray PB. Trypanosoma cruzi infection induces the expression of CD40 in murine cardiomyocytes favoring CD40 ligation-dependent production of cardiopathogenic IL-6. Parasitol Res. 2016 Feb;115(2):779-85. doi: 10.1007/s00436-015-4805-4. PMID: 26526953
• Duschak VG. Targets and patented drugs for chemotherapy of Chagas disease in the last 15 years-period. Recent Pat Antiinfect Drug Discov. 2016 Oct 24. PMID: 27784230
• Enriquez GF, Garbossa G, Macchiaverna NP, Argibay HD, Bua J, Gürtler RE, Cardinal MV. Is the infectiousness of dogs naturally infected with Trypanosoma cruzi associated with poly-parasitism? Vet Parasitol. 2016 Jun 15;223:186-94. doi: 10.1016/j.vetpar.2016.04.042. PMID: 27198799
• Ferrero MR, Heins AM, Soprano LL, Acosta DM, Esteva MI, Jacobs T, Duschak VG. Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E. Med Microbiol Immunol. 2016 Feb;205(1):21-35. doi: 10.1007/s00430-015-0421-2. PMID: 26047932
• Garavaglia PA, Laverrière M, Cannata JJ, García GA. Putative Role of the Aldo-Keto Reductase from Trypanosoma cruzi in Benznidazole Metabolism. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2664-70. doi: 10.1128/AAC.02185-15. PMID: 26856844
• Juiz NA, Cayo NM, Burgos M, Salvo ME, Nasser JR, Búa J, Longhi SA, Schijman AG. Human Polymorphisms in Placentally Expressed Genes and Their Association With Susceptibility to Congenital Trypanosoma cruzi Infection. J Infect Dis. 2016 Apr 15;213(8):1299-306. doi: 10.1093/infdis/jiv561. PMID: 26597259
• Lauricella MA, Maidana CG, Frias VF, Romagosa CM, Negri V, Benedetti R, Sinagra AJ, Luna C, Tartaglino L, Laucella S, Reed SG, Riarte AR. An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin America.Am J Trop Med Hyg. 2016 Jul 6;95(1):92-8. doi: 10.4269/ajtmh.13-0768. PMID: 27162270
• Scalise ML, Arrúa EC, Rial MS, Esteva MI, Salomon CJ, Fichera LE. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies. Am J Trop Med Hyg. 2016 Aug 3;95(2):388-93. doi: 10.4269/ajtmh.15-0889. PMID: 27246447
• Volta BJ, Bustos PL, Cardoni RL, De Rissio AM, Laucella SA, Bua J. Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure. J Immunol. 2016 Jun 1;196(11):4596-602. doi: 10.4049/jimmunol.1502504. PMID: 27183607
• Sartor P, Colaianni I, Cardinal MV, Bua J, Freilij H, Gürtler RE. Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation. PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005336. doi: 10.1371/journal.pntd.0005336. PMID: 28192425
• Bustos PL, Volta BJ, Perrone AE, Milduberger N, Bua J. A homolog of cyclophilin D is expressed in Trypanosoma cruzi and is involved in the oxidative stress-damage response. Cell Death Discov. 2017 Feb 6;3:16092. doi: 10.1038/cddiscovery.2016.92. PMID: 28179991
• Rivero R, Bisio M, Velázquez EB, Esteva MI, Scollo K, González NL, Altcheh J, Ruiz AM. Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): A potential novel tool for the detection of congenital Chagas infection. Diagn Microbiol Infect Dis. 2017 Sep;89(1):26-28. doi: 10.1016/j.diagmicrobio.2017.06.012. Epub 2017 Jun 19. PMID:28684052
• Rojas F, Koszela J, Búa J, Llorente B, Burchmore R, Auer M, Mottram JC, Téllez-Iñón MT. The ubiquitin-conjugating enzyme CDC34 is essential for cytokinesis in contrast to putative subunits of a SCF complex in Trypanosoma brucei. PLoS Negl Trop Dis. 2017 Jun 13;11(6):e0005626. doi: 10.1371/journal.pntd.0005626. [Epub ahead of print] PMID: 28609481
• Vilma G Duschak. Advances in the Neglected Chagas Disease: Drug Targets and Trypanocide Compounds. Curr Trends Biomedical Eng & Biosci. 2017; 6(4): 555693. DOI: 10.19080/CTBEB.2017.06.555693.
• Hong XK, Zhang X, Fusco OA, Lan YG, Lun ZR, Lai DH. PCR-based identification of Trypanosoma lewisi and Trypanosoma musculi using maxicircle kinetoplast DNA. Acta Trop. 2017 Jul;171:207-212. doi: 10.1016/j.actatropica.2017.04.007. Epub 2017 Apr 17.
• González L1, García-Huertas P, Triana-Chávez O, García GA, Murta SMF, Mejía-Jaramillo AM. Aldo-keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi. Mol Microbiol. 2017 Sep 7. doi: 10.1111/mmi.13830. [Epub ahead of print]
• Bustos PL, Perrone AE, Milduberger NA, Bua J. Mitochondrial permeability transition in protozoan parasites: what we learned from Trypanosoma cruzi. Cell Death Dis. 2017 Sep 21;8(9):e3057. doi: 10.1038/cddis.2017.431. PMID: 28933785
• Castro Eiro MD, Alvarez MG, Cooley G, Viotti RJ, Bertocchi GL, Lococo B, Albareda MC, De Rissio AM, Natale MA, Parodi C, Tarleton RL, Laucella SA. The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects. Front Immunol. 2017 Sep 15;8:1141. doi: 10.3389/fimmu.2017.01141. eCollection 2017. PMID:28966620
• Pascuale CA, Burgos JM, Postan M, Lantos AB, Bertelli A, Campetella O, Leguizamón MS. Inactive trans-Sialidase Expression in iTS-null Trypanosoma cruzi Generates Virulent Trypomastigotes. Front Cell Infect Microbiol. 2017 Oct 4;7:430. doi: 10.3389/fcimb.2017.00430. eCollection 2017. PMID: 29046868
• Rial MS, Scalise ML, Arrúa EC, Esteva MI, Salomon CJ, Fichera LE. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0006119. doi: 10.1371/journal.pntd.0006119. [Epub ahead of print]. PMID: 29267280
• Soprano LL, Parente JE, Landoni M, Couto AS, Duschak VG.Trypanosoma cruzi serinecarboxipeptidase is a sulfated glycoprotein and a minor antigen in human Chagas disease infection. Med Microbiol Immunol. 2017 Dec 22. doi: 10.1007/s00430-017-0529-7. [Epub ahead of print]. PMID: 2927401
• Carolina I. Cura, Juan C. Ramírez, Marcelo Rodríguez, Constanza Lopez Albízu, Lucía Irazu, Karenina Scollo, Sergio Sosa-Estani.Comparative Study and Analytical Verification of PCR Methods for the Diagnosis of Congenital Chagas Disease. The Journal of Molecular Diagnostics. September 2017.Vol 19 (5): 673-681.
• Lucas Gonzalez#, Karenina Scollo#, Ariel Bardach, Amadeo Sáez-Alquezar, Carina Ferlín, Pedro Albajar-Viñas, Agustín Ciapponi, Sergio Sosa-Estani.
• Inmunoserología y métodos moleculares para el diagnóstico de Chagas: revisión sistemática rápida. Acta Bioquím Clín Latinoam 2017; 51 (1): 63-74
• Carlos A. Morillo, Hetty Waskin, Sergio Sosa-Estani, Maria del Carmen Bangher, Carlos Cuneo, Rodolfo Milesi, Marcelo Mallagray, Werner Apt, Juan Beloscar, Joaquim Gascon, Israel Molina, Luis E. Echeverria, Hugo Colombo, Jose Antonio Perez-Molina, Fernando Wyss, Brandi Meeks, Laura R. Bonilla, Peggy Gao, Bo Wei, Michael McCarthy, Salim Yusuf, STOP-CHAGAS Investigators, Carlos Morillo, Sergio Sosa-Estani, Hetty Waskin, Brandi Meeks, Salim Yusuf, Rafael Diaz, Harry Acquatella, Julio Lazzari, Robin Roberts, Mahmoud Traina, Brandi Meeks, Laura R. Bonilla, Peggy Gao, Amanda Taylor, Iris Holadyk-Gris, Lindsey Whalen, M.C. Bangher, M.A. Romero, N. Prado, Y. Hernández, M. Fernandez, A. Riarte, K. Scollo, C. Lopez-Albizu, C.A. Cuneo, N.C. Gutiérrez, R.R. Milesi, M.A. Berli, M.H. Mallagray, N.E. Cáceres, J.S. Beloscar, J.M. Petrucci, H. Colombo, M. Dellatorre, Aldo Prado, W. Apt, I. Zulantay, L.E. Echeverría, D. Isaza, E. Reyes, F.S. Wyss, A. Figueroa, I. Guzmán Melgar, E. Rodríguez, J. Gascon, E. Aldasoro, E.J. Posada, N. Serret, I. Molina, A. Sánchez-Montalvá, J.A. Perez-Molina, R. López-Vélez, P.A. Reyes-López. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers. Journal of the American College of Cardiology 69 (8) 939-947; DOI:10.1016/j.jacc.2016.12.023. Febrero 2017.
• Rial Marcela Silvina , Scalise María Luján , López Alarcón Micaela , Esteva Mónica Inés , Búa Jacqueline, Benatar Alejandro , Prado Nilda Graciela , Riarte Adelina Rosa , Fichera Laura Edith. Experimental combination therapy with low doses of Benznidazole and Allopurinol on chronic T. cruzi infection. En etapa de publicación : Revista Parasitology. 2017
• Marisa Liliana Fernández – MD, Yolanda Hernández– MD, Professional assitances, Karenina Scollo – MSc Department Chief, Mónica Ines Esteva – MSc, Department Chief Adelina Rosa Riarte– MD, Expert consultor., Nilda Graciela Prado– MSc, Department Chief. Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood. En etapa de publicación Journal of the Brazilian Society of Tropical Medicine – RSBMT-2017-0364. 2017

2018 – 2019

• Albareda MC., Natale MA., De Rissio AM., Fernandez M, Serjan A, Alvarez MG., Cooley G, Shen H, Viotti R, Bua J, Castro Eiro MD., Nuñez M, Fichera LE., Lococo B, Scollo K, Tarleton RL. and Laucella SA. Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes. Immunol., 13 September 2018 https://doi.org/10.3389/fimmu.2018.01958
• Fernández ML, Hernández Y., Scollo K., Esteva MI, Riarte AR, Prado NG. Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhoodRev Soc Bras Med Trop 51(4):557-559, July-August, 2018 doi: 10.1590/0037-8682-0364-2017
• Garavaglia PA, Rubio MF, Laverrière M, Tasso LM, Fichera LE, Cannata JJB, García GA. Trypanosoma cruzi: death phenotypes induced by ortho-naphthoquinone substrates of the aldo-keto reductase (TcAKR). Role of this enzyme in the mechanism of action of β-lapachone. 2018 Aug;145(9):1251-1259. doi: 10.1017/S0031182018000045. Epub 2018 Feb 5. PMID: 29400267
• Jiménez-Coello M, Shelite T, Castellanos-González A, Saldarriaga O, Rivero R, Ortega-Pacheco A, Acevedo-Arcique C, Amaya-Guardia K, Garg N, Melby P, Travi BL. Eficacia de la amplificación de la polimerasa con recombinasa para diagnosticar la infección por Trypanosoma cruzi en perros con alteraciones cardíacas en un área endémica de México. Vector de la enfermedad zoonótica. Agosto de 2018; 18 (8): 417-423. doi: 10.1089 / vbz.2017.2258. Epub 2018 16 de mayo. PMID: 29768103
• Natale MA, César GA, Alvarez MG, Castro Eiro MD, Lococo B, Bertocchi G, Albareda MC, Laucella SA. Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis. PLoS Negl Trop Dis. 2018 Dec 5;12(12):e0006998. doi: 10.1371/journal.pntd.0006998. eCollection 2018 Dec. PMID: 30517089.
• Pérez-Mazliah DE, Castro Eiro MD, Álvarez MG, Lococo B, Bertocchi G, César G, Natale MA, Albareda MC, Viotti R, Laucella SA. Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy. PLoS Negl Trop Dis. 2018 Oct 22;12(10):e0006887. doi: 10.1371/journal.pntd.0006887.
• Perrone , Milduberger N, Fuchs AG., Bustos L.P, Bua J . A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite Trypanosoma cruzi. Biomolecules 2018, 8(4), 132; https://doi.org/10.3390/biom8040132
• Piñero TA, Landoni M, Duschak VG, Katzin AM, Couto AS. Effect of tamoxifen on the sphingolipid biosynthetic pathway in the different intraerythrocytic stages of the apicomplexa Plasmodium falciparum. Biochem Biophys Res Commun. 2018 Feb 26. pii: S0006-291X(18)30429-7. doi: 10.1016/j.bbrc.2018.02.183.
• Quebrada Palacio LP, González MN, Hernandez-Vasquez Y, Perrone AE, Parodi-Talice A, Bua J, Postan M. Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates. PLoS One. 2018 Sep 5;13(9):e0203462. doi: 10.1371/journal.pone.0203462. eCollection 2018. PMID: 30183775
• Rial MS, Scalise ML, López Alarcón M, Esteva MI, Búa J, Benatar AF, Prado NG, Riarte AR, Fichera LE. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection. 2018 Oct 10:1-9. doi: 10.1017/S0031182018001567. PMID:30301480
• Rivero R. «Advances in molecular diagnosis of congenital Chagas disease» (2018). Newsletter nº. 8 Chagas Disease Clinical Research Platform
• Volta BJ, Perrone AE, Rivero R, Scollo K, Bustos PL, Bua J. Some Limitations for Early Diagnosis of Congenital Chagas Infection by PCR. 2018 Apr;141(Suppl 5):S451-S455. doi: 10.1542/peds.2016-3719.
• Girard MC, Acevedo GR, López L, Ossowski MS, Piñeyro MD, Grosso JP, Fernandez M, Hernández Vasquez Y, Robello C, Gómez KA. Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection. Immunology. 2018 Jul 4. doi: 10.1111/imm.12979.
• Benchetrit AG, Fernández M, Bava AJ, Corti M, Porteiro N, Martínez Peralta L. Clinical and epidemiological features of chronic Trypanosoma cruzi infection in patients with HIV/AIDS in Buenos Aires, Argentina. Int J Infect Dis. 2018 Feb;67:118-121. doi: 10.1016/j.ijid.2017.11.027. Epub 2017 Nov 28.
• Albareda MC, Natale MA, Cesar GL, Castro Eiro MD, Alvarez MG, Laucella SA. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease. Methods Mol Biol. 2019;1955:339-348. doi: 10.1007/978-1-4939-9148-8_25. PMID: 30868539
• Bustos PL, Milduberger N, Volta BJ, Perrone AE, Laucella SA, Bua J. Trypanosoma cruzi Infection at the Maternal-Fetal Interface: Implications of Parasite Load in the Congenital Transmission and Challenges in the Diagnosis of Infected Newborns. Front Microbiol. 2019 Jun 7;10:1250. doi: 10.3389/fmicb.2019.01250. eCollection 2019. Review. PMID: 31231337
• Duschak VG. Major Kinds of Drug Targets in Chagas Disease or American Trypanosomiasis. Curr Drug Targets. 2019;20(11):1203-1216. doi: 10.2174/1389450120666190423160804. PMID: 31020939
• Landoni M, Piñero T, Soprano LL, Garcia-Bournissen F, Fichera L, Esteva MI, Duschak VG, Couto AS. Tamoxifen acts on Trypanosoma cruzi sphingolipid pathway triggering an apoptotic death process. Biochem Biophys Res Commun. 2019 Aug 27;516(3):934-940. doi: 10.1016/j.bbrc.2019.06.149. Epub 2019 Jul 2. PMID: 31277939
• Macchiaverna NP, Enriquez GF, Bua J, Fernández MP, Sartor PA, Gürtler RE, Cardinal MV. Human infectiousness and parasite load in chronic patients seropositive for Trypanosoma cruzi in a rural area of the Argentine Chaco. Infect Genet Evol. 2019 Nov 1;78:104062. doi: 10.1016/j.meegid.2019.104062. [Epub ahead of print] PMID: 31683004
• Natale MA, Cesar G, Alvarez MG, Castro Eiro MD, Lococo B, Bertocchi G, Albareda MC, Laucella SA. Correction: Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis. PLoS Negl Trop Dis. 2019 Feb 26;13(2):e0007168. doi: 10.1371/journal.pntd.0007168. eCollection 2019 Feb. PMID: 30807593
• Pengue C, Cesar G, Alvarez MG, Bertocchi G, Lococo B, Viotti R, Natale MA, Castro Eiro MD, Cambiazzo SS, Perroni N, Nuñez M, Albareda MC, Laucella SA. Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease. PLoS One. 2019 Jun 14;14(6):e0218260. doi: 10.1371/journal.pone.0218260. eCollection 2019.PMID: 31199841
• Sanmarco LM, Eberhardt N, Bergero G, Quebrada Palacio LP, Adami PM, Visconti LM, Minguez ÁR, Hernández-Vasquez Y, Silva EAC, Morelli L, Postan M, Aoki MP. Monocyte glycolysis determines CD8+ T cell functionality in human Chagas disease. JCI Insight. 2019 Sep 19;4(18). pii: 123490. doi: 10.1172/jci.insight.123490. PMID: 31479429

2020 – 2021

• Alonso-Padilla J, Abril M, Alarcón de Noya B, Almeida IC, Angheben A, Araujo Jorge T, Chatelain E, Esteva MI, Gascón J, Grijalva MJ, Guhl F,Hasslocher-Moreno AM, López MC, Luquetti A, Noya O, Pinazo MJ, Ramsey JM, Ribeiro I, Ruiz AM, Schijman AG, Sosa-Estani S, Thomas MC, Torrico F, Zrein M, Picado A. Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008035. doi: 10.1371/journal.pntd.0008035. eCollection 2020 Apr.
• Álvarez MG, Ramírez JC, Bertocchi G, Fernández M, Hernández Y, Lococo B, Lopez-Albizu C, Schijman A, Cura C, Abril M, Laucella S , Tarleton RL, Natale MA, Castro Eiro M, Sosa-Estani S, Viotti R. New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: Clinical, parasitological and serological assessment after three years of follow-up. Antimicrob Agents Chemother. 2020 22 de junio: AAC.00439-20. doi: 10.1128 / AAC.00439-20. En línea antes de la impresión.PMID: 32571827
• Bertelli A, Sanmarco LM, Pascuale CA, Postan M, Aoki MP, Leguizamón MS. Anti-inflammatory Role of Galectin-8 During Trypanosoma cruzi Chronic Infection. Front Cell Infect Microbiol. 2020 Jul 2;10:285. doi: 10.3389/fcimb.2020.00285. eCollection 2020. PMID: 32714876
• Milduberger Natalia, Bustos Patricia L., Gonzalez Carolina, Perrone Alina E., Postan Miriam, Bua Jacqueline. Trypanosoma cruzi infection in Cyclophilin D deficient mice. Exp Parasitol 2021 Jan; 220:108044. doi: 10.1016/j.exppara.2020.108044. Epub 2020 Nov 27
• Parodi C, Barrio A, García Bustos MF, González Prieto AG, Pimentel J, Badano N, Albareda MC, Castro Eiro ME, Laucella SA, de Elizalde de Bracco MM. B cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis. Parasite Immunol. 2020 May 27:e12759. doi: 10.1111/pim.12759. Online ahead of print. PMID: 32460372
• Quebrada Palacio LP, Fernández ER, Hernández-Vásquez Y, Petray PB, Postan M. Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease. Front Cell Infect Microbiol. 2020 Mar 31;10:126. doi: 10.3389/fcimb.2020.00126. eCollection 2020.PMID: 32296649
• Rial Marcela S , Seremeta Katia P , Esteva MI , Búa Jacqueline , Salomon Claudio J , Fichera Laura E . In vitro studies and preclinical evaluation of benznidazole microparticles in the acute Trypanosoma cruzi murine model Parasitology. 2020 Dec 10;1-38. doi: 10.1017/S0031182020002310. Online ahead of print. PMID: 33298212
• Rial MS, Arrúa EC, Natale MA, Bua J, Esteva MI, Prado NG, Laucella SA, Salomon CJ, Fichera LE Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice. Journal of Antimicrobial Chemotherapy, dkaa101, https://doi.org/10.1093/jac/dkaa101. Published:10 April 2020.
• Rodríguez Matías Exequiel, Rizzi Mariana, Caeiro D., Yamil E. Masip, Alina Perrone, Daniel O. Sánchez, Jacqueline Búa, Valeria Tekiel “Transmigration of Trypanosoma cruzi trypomastigotes through 3D cultures resembling a physiological environment” Cellular Microbiology. 2020;e13207. https://doi.org/10.1111/cmi.13207
• Tasso LM, Bruballa AC, Garavaglia PA, Esteva MI, Albareda MC, García GA. Effect of the Tc13Tul antigen from Trypanosoma cruzi on splenocytes from naïve mice. Parasitology. 2020 May 29:1-39. doi: 10.1017/S0031182020000864. Online ahead of print. PMID: 32466805
• Fernández ML, Marson ME, Mastrantonio GE, Corti MA, Fleitas U, Lloveras SC, Lista N, Priarone MM, Domínguez C, Garcia-Bournissen F. Benznidazole in cerebrospinal fluid. A case series of chagas disease meningoencephalitis in hiv positive patients. Antimicrob Agents Chemother. 2020 Dec 23:AAC.01922-20. doi: 10.1128/AAC.01922-20. Online ahead of print. PMID: 33361290
• Lopez-Albizu C, Bravo MP, Pico M, Fernandez ML.Case report of Chagas disease reactivation: new diagnosis tool by direct microscopic observation of biopsy specimen and its preservation fluid. Rev Soc Bras Med Trop. 2020 Dec 21;54:e20200326. doi: 10.1590/0037-8682-0326-2020. eCollection 2020. PMID: 33338120
• Besuschio SA, Picado A, Muñoz-Calderón A, Wehrendt DP, Fernández M, Benatar A, Diaz-Bello Z, Irurtia C, Cruz I, Ndung’u JM, Cafferata ML, Montenegro G, Sosa Estani S, Lucero RH, Alarcón de Noya B, Longhi SA, Schijman AG. Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation. PLoS Negl Trop Dis. 2020 Aug 14;14(8):e0008402. doi: 10.1371/journal.pntd.0008402. eCollection 2020 Aug. PMID: 32797041
• Álvarez MG, Ramírez JC, Bertocchi G, Fernández M, Hernández Y, Lococo B, Lopez-Albizu C, Schijman A, Cura C, Abril M, Laucella S, Tarleton RL, Natale MA, Castro Eiro M, Sosa-Estani S, Viotti R. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00439-20. doi: 10.1128/AAC.00439-20. Print 2020 Aug 20. PMID: 32571827
• Molina-Morant D, Fernández ML, Bosch-Nicolau P, Sulleiro E, Bangher M, Salvador F, Sanchez-Montalva A, Ribeiro ALP, de Paula AMB, Eloi S, Correa-Oliveira R, Villar JC, Sosa-Estani S, Molina I. Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial. Trials. 2020 Apr 15;21(1):328. doi: 10.1186/s13063-020-4226-2. PMID: 32293523
• Acevedo GR, Juiz NA, Ziblat A, Pérez Perri L, Girard MC, Ossowski MS, Fernández M, Hernández Y, Chadi R, Wittig M, Franke A, Nielsen M, Gómez KA. In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T Cells from Chagas’ Disease Patients. J Immunol. 2020 Mar 15;204(6):1571-1581. doi: 10.4049/jimmunol.1900873. Epub 2020 Feb 14. PMID: 32060134
• Cianciulli TF, Albarracín GA, Napoli Llobera M, Prado NG, Saccheri MC, Hernández Vásquez YM, Méndez RJ, Beck MA, Baez KG, Balletti LR. Speckle tracking echocardiography in the indeterminate form of Chagas disease. Echocardiography. 2020 Nov 3. doi: 10.1111/echo.14917. Online ahead of print. PMID: 33140890
• Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, Prado N, Riarte A, Torrico F, Ribeiro I, Villar JC, Sosa-Estani S. Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008529. doi: 10.1371/journal.pntd.0008529. eCollection 2020 Aug. PMID: 32804966
• Cianciulli TF, Saccheri MC, Papantoniou A, Prado NG, Riarte AR, Méndez RJ, Clérici JE, Beck MA, Lax JA, Gagliardi JA. Clinical significance of tissue Doppler imaging in chronic Chagas disease. Echocardiography. 2020 Aug;37(8):1205-1212. doi: 10.1111/echo.14795. Epub 2020 Jul 20. PMID: 32686870
• Cianciulli TF, Saccheri MC, Papantoniou A, Méndez RJ, Gagliardi JA, Prado NG, Riarte AR, Morita LA, Clérici JE, Lax JA. Use of tissue doppler imaging for the early detection of myocardial dysfunction in patients with the indeterminate form of Chagas disease. Rev Soc Bras Med Trop. 2020 Feb 21;53:e20190457. doi: 10.1590/0037-8682-0457-2019. eCollection 2020. PMID: 32130325
• Macchiaverna NP, Enriquez GF, Bua J, Fernández MP, Sartor PA, Gürtler RE, Cardinal MV. Human infectiousness and parasite load in chronic patients seropositive for Trypanosoma cruzi in a rural area of the Argentine Chaco. Infect Genet Evol. Mar;78:104062. doi: 10.1016/j.meegid.2019.104062. Epub 2019 Nov 1. PMID: 31683004.
• Crudo F, Piorno P, Krupitzki H, Guilera A, Lopez-Albizu C, Danesi E, Scollo K,Lloveras S, Mir S, Alvarez M , Yudis S, Cayo – Fernández MA, Cipri D, Krolewiecki A, Pereiro AC, Periago MV, Abril MC, Fernández M. How to implement the framework for the elimination of mother-to-child transmission of HIV, syphilis, hepatitis B and Chagas (EMTCT Plus) in a disperse rural population from the Gran Chaco region: A tailor-made program focused on pregnant women. PLOS Neglected Tropical Diseases, May 28, 2020. https://doi.org/10.1371/journal.pntd.0008078
• Lopez-Albizu C, Danesi E , Piorno P, Fernández M, García-Campos F, Scollo K, Favio Crudo F. Rapid Diagnostic Tests for Trypanosoma cruzi Infection: Field Evaluation of Two Registered Kits in a Region of Endemicity and a Region of Nonendemicity in Argentina. Journal of Clinical Microbiology. December 2020 Volume 58 Issue 12 e01140-20.
• Alonso-Padilla J, López MC, Esteva M, Zrein M, Casellas A, Gómez I, Granjon E, Méndez S, Benítez C, Ruiz AM, Sanz S, Gascón J, Thomas MC, Pinazo MJ; NHEPACHA Study Group. Serological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease. Acta Trop. 2021 Sep;221:105990. doi: 10.1016/j.actatropica.2021.105990. Epub 2021 Jun 6.PMID: 34090864
• Benatar AF, Danesi E, Besuschio SA, Bortolotti S, Cafferata ML, Ramirez JC, Albizu CL, Scollo K, Baleani M, Lara L, Agolti G, Seu S, Adamo E, Lucero RH, Irazu L, Rodriguez M, Poeylaut-Palena A, Longhi SA, Esteva M, Althabe F, Rojkin F, Bua J, Sosa-Estani S, Schijman AG; Congenital Chagas Disease Study Group. Prospective multicenter evaluation of real time PCR Kit prototype for early diagnosis of congenital Chagas disease. 2021 Jul;69:103450. doi: 10.1016/j.ebiom.2021.103450. Epub 2021 Jun 26.PMID: 34186488
• Bisio MMC, Rivero R, Gonzalez N, Ballering G, D’Amico I, Kessler C, Moroni S, Moscatelli G, Ruiz AM, Altcheh J. Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease. Mol Diagn Ther. 2021 Nov;25(6):791-801. doi: 10.1007/s40291-021-00553-3. Epub 2021 Aug 23.PMID: 34426953
• Castro Eiro MD, Natale MA, Alvarez MG, Shen H, Viotti R, Lococo B, Bua J, Nuñez M, Bertocchi GL, Albareda MC, Cesar G, Tarleton RL, Laucella SA. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.J Antimicrob Chemother. 2021 May 12;76(6):1580-1592. Doi: 10.1093/jac/dkab054.PMID: 33693664
• Milduberger N, Bustos PL, González C, Perrone AE, Postan M, Bua J. Trypanosoma cruzi infection in Cyclophilin D deficient mice. Exp Parasitol. 2021 Jan;220:108044. doi: 10.1016/j.exppara.2020.108044. Epub 2020 Nov 27.PMID: 33253715
• Natale MA, Minning T, Albareda MC, Castro Eiro MD, Álvarez MG, Lococo B, Cesar G, Bertocchi G, Elias MJ, Caputo MB, Tarleton RL, Laucella SA. Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro. PLoS Negl Trop Dis. 2021 Jun 1;15(6):e0009473. doi: 10.1371/journal.pntd.0009473. eCollection 2021 Jun.PMID: 34061845
• Rial MS, Seremeta KP, Esteva MI, Búa J, Salomon CJ, Fichera LE. In vitrostudies and preclinical evaluation of benznidazole microparticles in the acute Trypanosoma cruzi murine model. 2021 Apr;148(5):566-575. doi: 10.1017/S0031182020002310. Epub 2020 Dec 10.PMID: 33298212
• Soprano LL, Ferrero MR, Landoni M, García GA, Esteva MI, Couto AS, Duschak VG. Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruziInfection in the BALB/c Mice Model of Experimental Chagas Disease. Front Cell Infect Microbiol. 2022 Jan 4;11:814276. doi: 10.3389/fcimb.2021.814276. eCollection 2021.PMID: 35059328
• Valera-Vera EA, Concepción JL, Cáceres AJ, Acevedo GR, Fernández M, Hernández Y, Digirolamo FA, Duschak VG, Soprano LL, Pereira CA, Miranda MR, Gómez KA. IgE antibodies against Trypanosoma cruzi arginine kinase in patients with chronic Chagas disease. Mol Immunol. 2021 Oct;138:68-75. doi: 10.1016/j.molimm.2021.06.024. Epub 2021 Aug 4.PMID: 34364074
• Viecenz JM, Garavaglia PA, Tasso LM, Maidana CG, Bautista Cannata JJ, García GA. Identification and biochemical characterization of an ATP-dependent dihydroxyacetone kinase from Trypanosoma cruzi. Exp Parasitol. 2021 Dec;231:108178. doi: 10.1016/j.exppara.2021.108178. Epub 2021 Nov 10.PMID: 34767777
• Volta BJ, Bustos PL, González C, Natale MA, Perrone AE, Milduberger N, Laucella SA, Bua J. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission. J Infect Dis. 2021 Sep 17;224(6):1086-1095. doi: 10.1093/infdis/jiab057.PMID: 33528501
• Duschak VG, Relevance of Sulfotopes in the Antigenic Structural Glycoconjugates of Trypanosoma cruzi, the Causal Agent of Chagas Disease, Identified by UV MALDI-TOFAnalysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 101:224-225. DOI:10.1016/j.ijid.2020.11.023
• Miriam Postan and Martin E. Rottenberg. Editorial: Neurotropism of Parasites and the Immune Responses Editorial Published on 01 October 2021 Front. Immunol. doi: 10.3389/fimmu.2021.775666

2022

• Albareda MC, Álvarez MG, Caputo MB, Cesar G, Elías J y Laucella SA. Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease. Frontiers in Cellular and Infection Microbiology. DOI=10.3389/fcimb.2022.910854
• Albareda MC, Álvarez MG, Balbaryski J, Bertocchi GL, Caputo MB, Castro A, Castro Eiro MD, Cesar G, Elías MJ, Fernández M, Gaddi E, Laucella SA, Lococo B, Mazzuoccolo L, Natale MA, Seigelshifer D, Vigliano CA y Viotti R. Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole. Microbiol Spectr. 2022 Aug 8:e0135722. doi: 10.1128/spectrum.01357-22.
• Altcheh J, Bisio MMC, García-Bournissen F, Gulin JEN, Rocco D y Solana ME. Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy. Front Cell Infect Microbiol. 2022 Jul 5;12:855119. doi: 10.3389/fcimb.2022.855119.
• Argibay HD, Bua J, Cardinal MV, Enriquez GF, Fernández MDP, Gürtler RE, Macchiaverna NP, Orozco MM y Otegui JAA. Over-dispersed Trypanosoma cruzi parasite load in sylvatic and domestic mammals and humans from northeastern Argentina. Parasit Vectors. 2022 Jan 24;15(1):37. doi: 10.1186/s13071-022-05152-7.
• Bisio MMC y Rivero R. La respuesta del sistema científico tecnológico frente al COVID-19 como oportunidad para repensar el diagnóstico de Chagas. Ciencia e Investigación.Buenos Aires: Asociación Argentina para el Progreso de las Ciencias. 2022 vol.72 n°3. p5 - 13. ISSN 1132-0974.
• Danesi E, Yael Maltz T, Blanco J, Peyrán P, Carbajal-De-La-Fuente AL, Fernández ML.Experiencias del personal de salud sobre la implementación de prácticas de protección contra COVID-19 en la Argentina. 2022 (marzo). Actualizaciones en sida e infectología. Buenos Aires. Volumen 30. Número 108: 28-41. ASEI 108 ISSN 2718-7845.
• Duschak VG. Proteomics Loans in Kinetoplastids during the Last Decade. Bioinformatics & Proteomics. Open Access Journal. ISSN: 2642-6129. Volume 6 Issue 1. Received Date: March 07, 2022 Published Date: March 22, 2022. DOI: 10.23880/bpoj-16000148.
• Duschak VG. Emerging, re-emerging and neglected infectious diseases. Frontiers in Infectious diseases and Microbiology ISSN: 2771-1838. 2022; 2: 111.
• Duschak VG. Sulfatación y sulfotopes en Trypanosoma cruzi, agente causal de la enfermedad de Chagas. Ciencia e Investigación – Vol. 72 Nº 3 p 59-78.
• Lopez Albizu C, Rivero R, Ballering G, Bisio MMC. Diagnóstico de laboratorio de la infección humana por Trypanosoma cruzi Desafíos en la región de las Américas. Rev. Hosp. Niños (B. Aires) 2022;64(286):145-159.
• López SM, Hernández Vásquez Y y Riarte A. La enfermedad de Chagas, una perspectiva psicosocial. Revista Ciencia e Investigación, 2022, Tomo 72 Nº 3, (SAP), pág.: 14 a 23. https://aargentinapciencias.org/wp-content/uploads/2022/08/Revista-CeI72-3.pdf
• Muñoz-Calderón AA, Besuschio SA, Wong S, Fernández M, García Cáceres LJ, Giorgio P, Barcan LA, Markham C, Liu YE, de Noya BA, Longhi SA y Schijman AG. Loop-Mediated Isothermal Amplification of Trypanosoma cruzi DNA for Point-of-Care Follow-Up of Anti-Parasitic Treatment of Chagas Disease. Microorganisms. 2022 Apr 26;10(5):909. doi: 10.3390/microorganisms10050909.
• Ferragut F, Cruz KM, Gallardo JP, Fernández M, Hernández Vasquez Y, Gómez KAActivation-induced marker assays for identification of Trypanosoma cruzi-specific CD4 or CD8 T cells in chronic Chagas disease patients. Immunology. 2022 Dec 25. doi: 10.1111/imm.13622. Online ahead of print.
• Cesar G, Natale MA, Albareda MC, Alvarez MG, Lococo B, De Rissio AM, Fernandez M, Castro Eiro M, Bertocchi G, White BE, Zabaleta F, Viotti R, Tarleton RL, Laucella SA.B cell responses in chronic Chagas disease: Waning of Trypanosoma cruzi-specific antibody-secreting cells following successful etiological treatment. J Infect Dis. 2022 Dec 26:jiac495. doi: 10.1093/infdis/jiac495
• Castro Eiro MD, Natale MA, Alvarez MG, Castro A, Seigelshifer D, Viotti R, Fernández M, Mazzuoccolo L, Lococo B, Bertocchi GL, Cesar G, Albareda MC, Elias MJ, Caputo MB, Gaddi E, Balbaryski J, Vigliano CA, Laucella SAMixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole. . Microbiol Spectr. 2022 Aug 31;10(4):e0135722. doi: 10.1128/spectrum.01357-22. Epub 2022 Aug 8.
• Fernandez ML, Benchetrit A, Astudillo OG, Garay AM, De Vedia L, Garcia Bournissen F, Lloveras SC, Orduna TA, Gonzalez GD. COVID-19 and Chagas Disease in Buenos Aires, Argentina. . Front. Trop. Dis, 15 Feb 2022. https://doi.org/10.3389/fitd.2021.779428